| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium channel activity | 1.10e-05 | 129 | 215 | 9 | GO:0005262 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 3.88e-05 | 151 | 215 | 9 | GO:0015085 | |
| GeneOntologyMolecularFunction | G protein activity | 4.07e-05 | 59 | 215 | 6 | GO:0003925 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 4.21e-05 | 118 | 215 | 8 | GO:0003774 | |
| GeneOntologyMolecularFunction | monocarboxylic acid transmembrane transporter activity | 5.33e-05 | 90 | 215 | 7 | GO:0008028 | |
| GeneOntologyMolecularFunction | actin binding | MYO5A MYO5B ANXA8L1 GBP1 GBP2 GBP3 FMNL2 NF2 BAIAP2L1 FMNL1 MYO1H ANXA8 LMOD2 YWHAH FMNL3 MYO16 | 6.65e-05 | 479 | 215 | 16 | GO:0003779 |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | SLCO1B3 ABCD3 GRIN3A SLC22A20P ABCC11 GRIK1 GRIN2C SLCO1B1 SLC6A6 SLC6A13 SLC16A1 SLCO2A1 | 8.42e-05 | 293 | 215 | 12 | GO:0008514 |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | SLCO1B3 ABCD3 GRIN3A ABCC11 GRIK1 GRIN2C SLCO1B1 SLC6A6 SLC6A13 SLC16A1 | 8.60e-05 | 207 | 215 | 10 | GO:0046943 |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | SLCO1B3 ABCD3 GRIN3A ABCC11 GRIK1 GRIN2C SLCO1B1 SLC6A6 SLC6A13 SLC16A1 | 8.95e-05 | 208 | 215 | 10 | GO:0005342 |
| GeneOntologyMolecularFunction | arachidonate 5-lipoxygenase activity | 1.15e-04 | 2 | 215 | 2 | GO:0004051 | |
| GeneOntologyMolecularFunction | endopeptidase inhibitor activity | 1.50e-04 | 180 | 215 | 9 | GO:0004866 | |
| GeneOntologyMolecularFunction | peptidase inhibitor activity | 2.00e-04 | 187 | 215 | 9 | GO:0030414 | |
| GeneOntologyMolecularFunction | GDP phosphatase activity | 2.52e-04 | 12 | 215 | 3 | GO:0004382 | |
| GeneOntologyMolecularFunction | Hsp90 protein binding | 3.10e-04 | 55 | 215 | 5 | GO:0051879 | |
| GeneOntologyMolecularFunction | endopeptidase regulator activity | 3.41e-04 | 201 | 215 | 9 | GO:0061135 | |
| GeneOntologyMolecularFunction | taurine:sodium symporter activity | 3.44e-04 | 3 | 215 | 2 | GO:0005369 | |
| GeneOntologyMolecularFunction | prostaglandin transmembrane transporter activity | 4.10e-04 | 14 | 215 | 3 | GO:0015132 | |
| GeneOntologyMolecularFunction | phosphatidate phosphatase activity | 4.10e-04 | 14 | 215 | 3 | GO:0008195 | |
| GeneOntologyMolecularFunction | icosanoid transmembrane transporter activity | 5.09e-04 | 15 | 215 | 3 | GO:0071714 | |
| GeneOntologyMolecularFunction | long-chain fatty acyl-CoA dehydrogenase activity | 6.83e-04 | 4 | 215 | 2 | GO:0004466 | |
| GeneOntologyMolecularFunction | glutamate-gated receptor activity | 7.49e-04 | 17 | 215 | 3 | GO:0004970 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | HBS1L GBP7 MYO5B GBP1 GBP2 GBP3 GBP4 GBP5 RECQL5 ABCD3 CHD6 ATL2 RAP1A RAP1B ATL3 ABCC11 HELQ DNAH7 DNAH12 | 7.49e-04 | 775 | 215 | 19 | GO:0017111 |
| GeneOntologyMolecularFunction | pyrophosphatase activity | HBS1L GBP7 MYO5B GBP1 GBP2 GBP3 LHPP GBP4 GBP5 RECQL5 ABCD3 CHD6 ATL2 RAP1A RAP1B ATL3 ABCC11 HELQ DNAH7 DNAH12 | 7.70e-04 | 839 | 215 | 20 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | HBS1L GBP7 MYO5B GBP1 GBP2 GBP3 LHPP GBP4 GBP5 RECQL5 ABCD3 CHD6 ATL2 RAP1A RAP1B ATL3 ABCC11 HELQ DNAH7 DNAH12 | 7.81e-04 | 840 | 215 | 20 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | HBS1L GBP7 MYO5B GBP1 GBP2 GBP3 LHPP GBP4 GBP5 RECQL5 ABCD3 CHD6 ATL2 RAP1A RAP1B ATL3 ABCC11 HELQ DNAH7 DNAH12 | 7.81e-04 | 840 | 215 | 20 | GO:0016818 |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | DCDC1 MYO5A MYO5B ANXA8L1 GBP1 GBP2 GBP3 TOGARAM1 NEDD1 FMNL2 NF2 BAIAP2L1 PLK1 FMNL1 APPBP2 MYO1H ANXA8 LMOD2 YWHAH FMNL3 PPP5C MACO1 MAST1 MYO16 | 7.97e-04 | 1099 | 215 | 24 | GO:0008092 |
| GeneOntologyMolecularFunction | actin filament binding | 8.19e-04 | 227 | 215 | 9 | GO:0051015 | |
| GeneOntologyMolecularFunction | sodium-independent organic anion transmembrane transporter activity | 8.91e-04 | 18 | 215 | 3 | GO:0015347 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | SPNS1 TRPC1 SIDT1 SLCO1B3 CATSPER3 ITGAV CLCN2 ABCD3 TRPM1 GRIN3A SLC22A20P TRPC7 ABCC11 GRIK1 GRIN2C SLCO1B1 SLC6A6 SLC6A13 SLC25A36 CACNG7 SLC46A3 SLC16A1 SLCO2A1 SLC22A4 SLC14A2 | 9.52e-04 | 1180 | 215 | 25 | GO:0022857 |
| GeneOntologyMolecularFunction | amino acid transmembrane transporter activity | 9.65e-04 | 105 | 215 | 6 | GO:0015171 | |
| GeneOntologyMolecularFunction | insulin-like growth factor binding | 1.05e-03 | 19 | 215 | 3 | GO:0005520 | |
| GeneOntologyMolecularFunction | secondary active monocarboxylate transmembrane transporter activity | 1.05e-03 | 19 | 215 | 3 | GO:0015355 | |
| GeneOntologyMolecularFunction | lipid phosphatase activity | 1.05e-03 | 19 | 215 | 3 | GO:0042577 | |
| GeneOntologyMolecularFunction | taurine transmembrane transporter activity | 1.13e-03 | 5 | 215 | 2 | GO:0005368 | |
| GeneOntologyMolecularFunction | pyruvate dehydrogenase (acetyl-transferring) kinase activity | 1.13e-03 | 5 | 215 | 2 | GO:0004740 | |
| GeneOntologyMolecularFunction | lipid transmembrane transporter activity | 1.15e-03 | 73 | 215 | 5 | GO:0170055 | |
| GeneOntologyMolecularFunction | GTPase activity | 1.22e-03 | 341 | 215 | 11 | GO:0003924 | |
| GeneOntologyMolecularFunction | nucleoside diphosphate phosphatase activity | 1.23e-03 | 20 | 215 | 3 | GO:0017110 | |
| GeneOntologyMolecularFunction | GTP binding | HBS1L GBP7 GBP1 GBP2 GBP3 GBP4 GBP5 ACSM5 ATL2 RAP1A RAP1B ATL3 | 1.29e-03 | 397 | 215 | 12 | GO:0005525 |
| GeneOntologyMolecularFunction | transporter activity | SPNS1 TRPC1 SIDT1 SLCO1B3 CATSPER3 ITGAV CLCN2 ABCD3 TRPM1 GRIN3A SLC22A20P TRPC7 ABCC11 GRIK1 GRIN2C SLCO1B1 SLC6A6 SLC6A13 SLC25A36 CACNG7 SLC46A3 SLC16A1 SLCO2A1 SLC22A4 LRP2 SLC14A2 | 1.52e-03 | 1289 | 215 | 26 | GO:0005215 |
| GeneOntologyMolecularFunction | gamma-aminobutyric acid:sodium:chloride symporter activity | 1.68e-03 | 6 | 215 | 2 | GO:0005332 | |
| GeneOntologyMolecularFunction | peptidase regulator activity | 1.94e-03 | 257 | 215 | 9 | GO:0061134 | |
| GeneOntologyMolecularFunction | heat shock protein binding | 1.97e-03 | 163 | 215 | 7 | GO:0031072 | |
| GeneOntologyMolecularFunction | enzyme inhibitor activity | GBP1 SLCO1B3 GBP2 GBP3 BIRC6 GBP5 RPTOR C5 YWHAG SERPINA12 TIMP3 WDTC1 | 2.76e-03 | 435 | 215 | 12 | GO:0004857 |
| GeneOntologyMolecularFunction | guanyl ribonucleotide binding | HBS1L GBP7 GBP1 GBP2 GBP3 GBP4 GBP5 ACSM5 ATL2 RAP1A RAP1B ATL3 | 2.97e-03 | 439 | 215 | 12 | GO:0032561 |
| GeneOntologyMolecularFunction | guanyl nucleotide binding | HBS1L GBP7 GBP1 GBP2 GBP3 GBP4 GBP5 ACSM5 ATL2 RAP1A RAP1B ATL3 | 2.97e-03 | 439 | 215 | 12 | GO:0019001 |
| GeneOntologyMolecularFunction | glutamate receptor activity | 2.98e-03 | 27 | 215 | 3 | GO:0008066 | |
| GeneOntologyMolecularFunction | glutamate-gated calcium ion channel activity | 3.10e-03 | 8 | 215 | 2 | GO:0022849 | |
| GeneOntologyMolecularFunction | NMDA glutamate receptor activity | 3.10e-03 | 8 | 215 | 2 | GO:0004972 | |
| GeneOntologyMolecularFunction | calcium-dependent protein serine/threonine phosphatase activity | 3.10e-03 | 8 | 215 | 2 | GO:0004723 | |
| GeneOntologyBiologicalProcess | positive regulation of pyroptotic inflammatory response | 8.49e-11 | 9 | 210 | 6 | GO:0140639 | |
| GeneOntologyBiologicalProcess | cytolysis in another organism | 8.49e-11 | 9 | 210 | 6 | GO:0051715 | |
| GeneOntologyBiologicalProcess | cytolysis | 9.11e-10 | 12 | 210 | 6 | GO:0019835 | |
| GeneOntologyBiologicalProcess | positive regulation of AIM2 inflammasome complex assembly | 1.04e-08 | 4 | 210 | 4 | GO:0140973 | |
| GeneOntologyBiologicalProcess | regulation of AIM2 inflammasome complex assembly | 1.54e-07 | 6 | 210 | 4 | GO:0140971 | |
| GeneOntologyBiologicalProcess | AIM2 inflammasome complex assembly | 7.08e-07 | 8 | 210 | 4 | GO:0140970 | |
| GeneOntologyBiologicalProcess | adhesion of symbiont to host | 1.43e-06 | 20 | 210 | 5 | GO:0044406 | |
| GeneOntologyBiologicalProcess | cellular response to interferon-beta | 3.46e-06 | 41 | 210 | 6 | GO:0035458 | |
| GeneOntologyBiologicalProcess | pyroptotic inflammatory response | 4.01e-06 | 42 | 210 | 6 | GO:0070269 | |
| GeneOntologyBiologicalProcess | response to interferon-beta | 8.91e-06 | 48 | 210 | 6 | GO:0035456 | |
| GeneOntologyBiologicalProcess | fatty acid metabolic process | ACADL MYO5A PDK2 PDK3 LPIN1 ACAD11 ABCD3 ACSM5 ACOT2 ALOX5 ALOX5AP HACD3 ASAH2 LPIN3 LPIN2 WDTC1 | 2.16e-05 | 461 | 210 | 16 | GO:0006631 |
| GeneOntologyBiologicalProcess | defense response to protozoan | 4.53e-05 | 39 | 210 | 5 | GO:0042832 | |
| GeneOntologyBiologicalProcess | ligand-gated ion channel signaling pathway | 5.14e-05 | 40 | 210 | 5 | GO:1990806 | |
| GeneOntologyBiologicalProcess | response to protozoan | 6.53e-05 | 42 | 210 | 5 | GO:0001562 | |
| GeneOntologyBiologicalProcess | positive regulation of protein-containing complex assembly | PCSK5 TRABD2B GBP1 GBP2 GBP3 TOGARAM1 BAIAP2L1 GBP5 RAP1B LMOD2 | 1.16e-04 | 227 | 210 | 10 | GO:0031334 |
| GeneOntologyBiologicalProcess | positive regulation of inflammasome-mediated signaling pathway | 1.31e-04 | 26 | 210 | 4 | GO:0141087 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | EPHB2 HIF1A MYO5A TRPC1 SLCO1B3 CATSPER3 ITGAV CLCN2 PLCB3 TRPM1 GRIN3A SLC22A20P TRPC7 ABCC11 GRIK1 GRIN2C SLCO1B1 YWHAH SLC6A6 SLC6A13 CACNG7 SLC46A3 PPP3CC PPP3R1 SLC16A1 ATP6AP2 SLC22A4 LRP2 LARGE1 | 1.52e-04 | 1374 | 210 | 29 | GO:0006811 |
| GeneOntologyBiologicalProcess | cellular response to oxygen-containing compound | EPHB2 HIF1A GBP7 MYO5A PDK2 PDK3 TRPC1 GBP1 GBP2 GBP3 LPIN1 GBP4 GBP5 RPTOR RECQL5 RAP1A RAP1B ANXA7 PRPF8 YWHAG SERPINA12 LPIN3 DNAI1 ASS1 LPIN2 BRINP2 SMARCB1 CTSD WDTC1 LARGE1 | 1.64e-04 | 1450 | 210 | 30 | GO:1901701 |
| GeneOntologyBiologicalProcess | cellular response to type II interferon | 1.68e-04 | 114 | 210 | 7 | GO:0071346 | |
| GeneOntologyBiologicalProcess | monocarboxylic acid metabolic process | HIF1A ACADL MYO5A PDK2 PDK3 LPIN1 ACAD11 RPTOR ABCD3 ACSM5 ACOT2 ALOX5 ALOX5AP HACD3 ASAH2 LPIN3 SLC16A1 LPIN2 WDTC1 | 1.83e-04 | 731 | 210 | 19 | GO:0032787 |
| GeneOntologyBiologicalProcess | cellular response to nitrogen compound | EPHB2 MYO5A PDK2 TRPC1 LPIN1 RPTOR RECQL5 RAP1A RAP1B ANXA7 YWHAG SERPINA12 LPIN3 DNAI1 ASS1 LPIN2 CTSD WDTC1 LARGE1 | 2.61e-04 | 752 | 210 | 19 | GO:1901699 |
| GeneOntologyBiologicalProcess | carnitine metabolic process | 2.76e-04 | 13 | 210 | 3 | GO:0009437 | |
| GeneOntologyBiologicalProcess | negative regulation of phospholipase A2 activity | 3.07e-04 | 3 | 210 | 2 | GO:1900138 | |
| GeneOntologyBiologicalProcess | leukotriene production involved in inflammatory response | 3.07e-04 | 3 | 210 | 2 | GO:0002540 | |
| GeneOntologyBiologicalProcess | positive regulation of cellular component biogenesis | EPHB2 PCSK5 HIF1A TRABD2B MYO5B GBP1 GBP2 GBP3 TOGARAM1 NF2 BAIAP2L1 GBP5 PAN2 RAP1B LMOD2 CNOT1 | 3.23e-04 | 582 | 210 | 16 | GO:0044089 |
| GeneOntologyBiologicalProcess | killing of cells of another organism | 3.59e-04 | 129 | 210 | 7 | GO:0031640 | |
| GeneOntologyBiologicalProcess | disruption of cell in another organism | 3.59e-04 | 129 | 210 | 7 | GO:0141061 | |
| GeneOntologyBiologicalProcess | disruption of anatomical structure in another organism | 4.13e-04 | 132 | 210 | 7 | GO:0141060 | |
| GeneOntologyBiologicalProcess | production of molecular mediator involved in inflammatory response | 4.32e-04 | 133 | 210 | 7 | GO:0002532 | |
| GeneOntologyBiologicalProcess | sodium-independent organic anion transport | 4.32e-04 | 15 | 210 | 3 | GO:0043252 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | EPHB2 HIF1A MYO5A TRPC1 CATSPER3 ITGAV CLCN2 PLCB3 TRPM1 GRIN3A TRPC7 ABCC11 GRIK1 GRIN2C YWHAH SLC6A6 SLC6A13 CACNG7 SLC46A3 PPP3CC PPP3R1 SLC16A1 ATP6AP2 LARGE1 | 4.42e-04 | 1115 | 210 | 24 | GO:0034220 |
| GeneOntologyCellularComponent | host intracellular region | 5.81e-10 | 6 | 210 | 5 | GO:0043656 | |
| GeneOntologyCellularComponent | host cell cytoplasm | 5.81e-10 | 6 | 210 | 5 | GO:0030430 | |
| GeneOntologyCellularComponent | host cell part | 5.81e-10 | 6 | 210 | 5 | GO:0033643 | |
| GeneOntologyCellularComponent | host intracellular part | 5.81e-10 | 6 | 210 | 5 | GO:0033646 | |
| GeneOntologyCellularComponent | host cell cytoplasm part | 5.81e-10 | 6 | 210 | 5 | GO:0033655 | |
| GeneOntologyCellularComponent | symbiont-containing vacuole | 5.81e-10 | 6 | 210 | 5 | GO:0020003 | |
| GeneOntologyCellularComponent | symbiont-containing vacuole membrane | 5.81e-10 | 6 | 210 | 5 | GO:0020005 | |
| GeneOntologyCellularComponent | host cellular component | 2.70e-07 | 15 | 210 | 5 | GO:0018995 | |
| GeneOntologyCellularComponent | symbiont cell surface | 6.71e-07 | 8 | 210 | 4 | GO:0106139 | |
| GeneOntologyCellularComponent | other organism part | 1.20e-06 | 9 | 210 | 4 | GO:0044217 | |
| GeneOntologyCellularComponent | dendrite | EPHB2 PCSK5 MYO5A MYO5B ADCY9 CKB CLCN2 RPTOR SORCS2 TRPM1 ALOX5 DNAJB1 LAMA2 GRIK1 INPP5F SLC6A6 PPP5C ATP6AP2 BRINP2 LRP2 MAST1 | 1.59e-04 | 858 | 210 | 21 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | EPHB2 PCSK5 MYO5A MYO5B ADCY9 CKB CLCN2 RPTOR SORCS2 TRPM1 ALOX5 DNAJB1 LAMA2 GRIK1 INPP5F SLC6A6 PPP5C ATP6AP2 BRINP2 LRP2 MAST1 | 1.64e-04 | 860 | 210 | 21 | GO:0097447 |
| GeneOntologyCellularComponent | basal plasma membrane | TRPC1 SLCO1B3 CLCN2 AP2A1 SLCO1B1 SLC6A6 SLC6A13 SLC16A1 SLCO2A1 SLC22A4 SLC14A2 NDRG4 | 2.57e-04 | 354 | 210 | 12 | GO:0009925 |
| GeneOntologyCellularComponent | basolateral plasma membrane | TRPC1 SLCO1B3 CLCN2 AP2A1 SLCO1B1 SLC6A6 SLC6A13 SLC16A1 SLCO2A1 SLC14A2 NDRG4 | 4.13e-04 | 320 | 210 | 11 | GO:0016323 |
| GeneOntologyCellularComponent | basal part of cell | TRPC1 SLCO1B3 CLCN2 AP2A1 SLCO1B1 SLC6A6 SLC6A13 SLC16A1 SLCO2A1 SLC22A4 SLC14A2 NDRG4 | 4.64e-04 | 378 | 210 | 12 | GO:0045178 |
| GeneOntologyCellularComponent | endoplasmic reticulum tubular network membrane | 9.85e-04 | 5 | 210 | 2 | GO:0098826 | |
| GeneOntologyCellularComponent | ionotropic glutamate receptor complex | 1.07e-03 | 45 | 210 | 4 | GO:0008328 | |
| GeneOntologyCellularComponent | cell body | EPHB2 PCSK5 MYO5A MYO5B CKB CLCN2 NF2 RPTOR SORCS2 GRIN3A DNAJB1 GRIK1 INPP5F SLC6A6 CACNG7 PPP5C ATP6AP2 ASS1 BRINP2 MAST1 | 1.14e-03 | 929 | 210 | 20 | GO:0044297 |
| GeneOntologyCellularComponent | somatodendritic compartment | EPHB2 PCSK5 MYO5A MYO5B ADCY9 CKB CLCN2 RPTOR SORCS2 TRPM1 GRIN3A ALOX5 DNAJB1 LAMA2 GRIK1 INPP5F SLC6A6 CACNG7 PPP5C ATP6AP2 ASS1 BRINP2 LRP2 MAST1 | 1.40e-03 | 1228 | 210 | 24 | GO:0036477 |
| GeneOntologyCellularComponent | calcineurin complex | 1.47e-03 | 6 | 210 | 2 | GO:0005955 | |
| GeneOntologyCellularComponent | neurotransmitter receptor complex | 1.59e-03 | 50 | 210 | 4 | GO:0098878 | |
| GeneOntologyCellularComponent | ficolin-1-rich granule lumen | 1.60e-03 | 124 | 210 | 6 | GO:1904813 | |
| GeneOntologyCellularComponent | axonemal dynein complex | 1.95e-03 | 25 | 210 | 3 | GO:0005858 | |
| GeneOntologyCellularComponent | neuronal cell body | EPHB2 PCSK5 MYO5A MYO5B CKB CLCN2 RPTOR SORCS2 GRIN3A DNAJB1 GRIK1 INPP5F SLC6A6 CACNG7 PPP5C ASS1 BRINP2 MAST1 | 1.98e-03 | 835 | 210 | 18 | GO:0043025 |
| GeneOntologyCellularComponent | dynein complex | 2.11e-03 | 54 | 210 | 4 | GO:0030286 | |
| Domain | GBP_C | 8.44e-15 | 10 | 206 | 8 | PF02841 | |
| Domain | G_GB1_RHD3_dom | 3.07e-14 | 11 | 206 | 8 | IPR030386 | |
| Domain | Guanylate-bd_N | 3.07e-14 | 11 | 206 | 8 | IPR015894 | |
| Domain | Guanylate-bd_C | 3.07e-14 | 11 | 206 | 8 | IPR003191 | |
| Domain | GBP | 3.07e-14 | 11 | 206 | 8 | PF02263 | |
| Domain | G_GB1_RHD3 | 3.07e-14 | 11 | 206 | 8 | PS51715 | |
| Domain | Lipin_N | 1.32e-06 | 3 | 206 | 3 | IPR007651 | |
| Domain | Lipin_mid | 1.32e-06 | 3 | 206 | 3 | IPR031703 | |
| Domain | Lipin_N | 1.32e-06 | 3 | 206 | 3 | PF04571 | |
| Domain | Lipin_mid | 1.32e-06 | 3 | 206 | 3 | PF16876 | |
| Domain | TPR-like_helical_dom | GTF3C3 TTC8 EIF3L TTC38 APPBP2 SGTB TTC28 COPS3 PPP5C SEL1L2 CDC27 EDRF1 WDTC1 | 1.99e-06 | 233 | 206 | 13 | IPR011990 |
| Domain | TPR_REGION | 1.52e-05 | 165 | 206 | 10 | PS50293 | |
| Domain | TPR | 1.52e-05 | 165 | 206 | 10 | PS50005 | |
| Domain | - | GTF3C3 TTC8 EIF3L TTC38 APPBP2 SGTB TTC28 PPP5C SEL1L2 EDRF1 WDTC1 | 1.96e-05 | 207 | 206 | 11 | 1.25.40.10 |
| Domain | LNS2 | 2.58e-05 | 6 | 206 | 3 | IPR013209 | |
| Domain | LNS2 | 2.58e-05 | 6 | 206 | 3 | SM00775 | |
| Domain | LNS2 | 2.58e-05 | 6 | 206 | 3 | PF08235 | |
| Domain | LNS2/PITP | 2.58e-05 | 6 | 206 | 3 | IPR031315 | |
| Domain | MFS | SPNS1 SLCO1B3 SLC22A20P SLCO1B1 SLC46A3 SLC16A1 SLCO2A1 SLC22A4 | 2.62e-05 | 108 | 206 | 8 | PS50850 |
| Domain | TPR-contain_dom | 4.40e-05 | 150 | 206 | 9 | IPR013026 | |
| Domain | 14_3_3 | 4.48e-05 | 7 | 206 | 3 | SM00101 | |
| Domain | 1433_1 | 4.48e-05 | 7 | 206 | 3 | PS00796 | |
| Domain | 1433_2 | 4.48e-05 | 7 | 206 | 3 | PS00797 | |
| Domain | 14-3-3_domain | 4.48e-05 | 7 | 206 | 3 | IPR023410 | |
| Domain | 14-3-3_CS | 4.48e-05 | 7 | 206 | 3 | IPR023409 | |
| Domain | 14-3-3 | 4.48e-05 | 7 | 206 | 3 | PF00244 | |
| Domain | TPR_1 | 6.18e-05 | 90 | 206 | 7 | IPR001440 | |
| Domain | TPR_1 | 6.18e-05 | 90 | 206 | 7 | PF00515 | |
| Domain | 14-3-3 | 7.11e-05 | 8 | 206 | 3 | IPR000308 | |
| Domain | TPR | 9.31e-05 | 129 | 206 | 8 | SM00028 | |
| Domain | Drf_GBD | 1.06e-04 | 9 | 206 | 3 | PF06371 | |
| Domain | Drf_FH3 | 1.06e-04 | 9 | 206 | 3 | PF06367 | |
| Domain | FH3_dom | 1.06e-04 | 9 | 206 | 3 | IPR010472 | |
| Domain | GTPase-bd | 1.06e-04 | 9 | 206 | 3 | IPR010473 | |
| Domain | Drf_FH3 | 1.06e-04 | 9 | 206 | 3 | SM01139 | |
| Domain | Drf_GBD | 1.06e-04 | 9 | 206 | 3 | SM01140 | |
| Domain | TPR_repeat | 1.15e-04 | 133 | 206 | 8 | IPR019734 | |
| Domain | AnnexinVIII | 1.21e-04 | 2 | 206 | 2 | IPR009115 | |
| Domain | MFS_dom | SPNS1 SLCO1B3 SLC22A20P SLCO1B1 SLC46A3 SLC16A1 SLCO2A1 SLC22A4 | 1.21e-04 | 134 | 206 | 8 | IPR020846 |
| Domain | P-loop_NTPase | HBS1L GBP7 MYO5A MYO5B GBP1 GBP2 GBP3 GBP4 GBP5 RECQL5 ABCD3 CHD6 ATL2 CNP RAP1A RAP1B ATL3 ABCC11 HELQ DNAH7 DNAH12 MYO16 | 1.78e-04 | 848 | 206 | 22 | IPR027417 |
| Domain | GBD/FH3_dom | 2.04e-04 | 11 | 206 | 3 | IPR014768 | |
| Domain | GBD_FH3 | 2.04e-04 | 11 | 206 | 3 | PS51232 | |
| Domain | OA_transporter | 2.70e-04 | 12 | 206 | 3 | IPR004156 | |
| Domain | OATP | 2.70e-04 | 12 | 206 | 3 | PF03137 | |
| Domain | ANX | 3.49e-04 | 13 | 206 | 3 | SM00335 | |
| Domain | Annexin_repeat_CS | 3.49e-04 | 13 | 206 | 3 | IPR018252 | |
| Domain | Annexin | 3.49e-04 | 13 | 206 | 3 | PF00191 | |
| Domain | Annexin_repeat | 3.49e-04 | 13 | 206 | 3 | IPR018502 | |
| Domain | ANNEXIN | 3.49e-04 | 13 | 206 | 3 | PS00223 | |
| Domain | - | 3.49e-04 | 13 | 206 | 3 | 1.10.220.10 | |
| Domain | Annexin | 4.40e-04 | 14 | 206 | 3 | IPR001464 | |
| Domain | FH2 | 5.46e-04 | 15 | 206 | 3 | PS51444 | |
| Domain | FH2_Formin | 5.46e-04 | 15 | 206 | 3 | IPR015425 | |
| Domain | FH2 | 5.46e-04 | 15 | 206 | 3 | PF02181 | |
| Domain | FH2 | 5.46e-04 | 15 | 206 | 3 | SM00498 | |
| Domain | - | HBS1L GBP7 GBP1 GBP2 GBP3 GBP4 GBP5 RECQL5 ABCD3 CHD6 ATL2 CNP RAP1A RAP1B ATL3 ABCC11 HELQ DNAH7 DNAH12 | 6.24e-04 | 746 | 206 | 19 | 3.40.50.300 |
| Domain | Ndr | 7.16e-04 | 4 | 206 | 2 | PF03096 | |
| Domain | NDRG | 7.16e-04 | 4 | 206 | 2 | IPR004142 | |
| Domain | Lig_chan-Glu_bd | 9.55e-04 | 18 | 206 | 3 | PF10613 | |
| Domain | Glu/Gly-bd | 9.55e-04 | 18 | 206 | 3 | IPR019594 | |
| Domain | Lig_chan-Glu_bd | 9.55e-04 | 18 | 206 | 3 | SM00918 | |
| Domain | Iontro_rcpt | 9.55e-04 | 18 | 206 | 3 | IPR001320 | |
| Domain | Iono_rcpt_met | 9.55e-04 | 18 | 206 | 3 | IPR001508 | |
| Domain | Lig_chan | 9.55e-04 | 18 | 206 | 3 | PF00060 | |
| Domain | PBPe | 9.55e-04 | 18 | 206 | 3 | SM00079 | |
| Domain | BCDHK_Adom3 | 1.18e-03 | 5 | 206 | 2 | PF10436 | |
| Domain | Laminin_domII | 1.18e-03 | 5 | 206 | 2 | IPR010307 | |
| Domain | Myosin_S1_N | 1.18e-03 | 5 | 206 | 2 | IPR008989 | |
| Domain | HSR | 1.18e-03 | 5 | 206 | 2 | PS51414 | |
| Domain | His_kinase_dom | 1.18e-03 | 5 | 206 | 2 | IPR005467 | |
| Domain | HIS_KIN | 1.18e-03 | 5 | 206 | 2 | PS50109 | |
| Domain | BCDHK/PDK_N | 1.18e-03 | 5 | 206 | 2 | IPR018955 | |
| Domain | Laminin_aI | 1.18e-03 | 5 | 206 | 2 | IPR009254 | |
| Domain | Laminin_I | 1.18e-03 | 5 | 206 | 2 | PF06008 | |
| Domain | Laminin_II | 1.18e-03 | 5 | 206 | 2 | PF06009 | |
| Domain | - | 1.18e-03 | 5 | 206 | 2 | 1.20.140.20 | |
| Domain | HSR | 1.18e-03 | 5 | 206 | 2 | PF03172 | |
| Domain | HSR_dom | 1.18e-03 | 5 | 206 | 2 | IPR004865 | |
| Domain | TRP_2 | 1.76e-03 | 6 | 206 | 2 | PF08344 | |
| Domain | Dilute_dom | 1.76e-03 | 6 | 206 | 2 | IPR002710 | |
| Domain | TRP_dom | 1.76e-03 | 6 | 206 | 2 | IPR013555 | |
| Domain | DIL | 1.76e-03 | 6 | 206 | 2 | PF01843 | |
| Domain | DILUTE | 1.76e-03 | 6 | 206 | 2 | PS51126 | |
| Domain | DIL | 1.76e-03 | 6 | 206 | 2 | SM01132 | |
| Domain | TRPC_channel | 2.45e-03 | 7 | 206 | 2 | IPR002153 | |
| Domain | DAD_dom | 3.24e-03 | 8 | 206 | 2 | IPR014767 | |
| Domain | SAND_dom | 3.24e-03 | 8 | 206 | 2 | IPR000770 | |
| Domain | Flavodoxin/NO_synth | 3.24e-03 | 8 | 206 | 2 | IPR008254 | |
| Domain | DAD | 3.24e-03 | 8 | 206 | 2 | PS51231 | |
| Domain | Flavdoxin-like | 3.24e-03 | 8 | 206 | 2 | IPR001094 | |
| Domain | FLAVODOXIN_LIKE | 3.24e-03 | 8 | 206 | 2 | PS50902 | |
| Domain | LAMININ_IVA | 3.24e-03 | 8 | 206 | 2 | PS51115 | |
| Domain | Laminin_B | 3.24e-03 | 8 | 206 | 2 | PF00052 | |
| Domain | Flavodoxin_1 | 3.24e-03 | 8 | 206 | 2 | PF00258 | |
| Domain | SAND | 3.24e-03 | 8 | 206 | 2 | PF01342 | |
| Domain | LamB | 3.24e-03 | 8 | 206 | 2 | SM00281 | |
| Domain | SAND | 3.24e-03 | 8 | 206 | 2 | PS50864 | |
| Domain | Laminin_IV | 3.24e-03 | 8 | 206 | 2 | IPR000034 | |
| Domain | SAND | 3.24e-03 | 8 | 206 | 2 | SM00258 | |
| Domain | rSAM | 4.14e-03 | 9 | 206 | 2 | IPR007197 | |
| Pathway | REACTOME_ACTIVATION_OF_BAD_AND_TRANSLOCATION_TO_MITOCHONDRIA | 1.09e-07 | 12 | 154 | 5 | MM14482 | |
| Pathway | REACTOME_ACTIVATION_OF_BAD_AND_TRANSLOCATION_TO_MITOCHONDRIA | 4.01e-07 | 15 | 154 | 5 | M26902 | |
| Pathway | REACTOME_ACTIVATION_OF_BH3_ONLY_PROTEINS | 1.11e-06 | 18 | 154 | 5 | MM14510 | |
| Pathway | KEGG_OOCYTE_MEIOSIS | 3.98e-06 | 113 | 154 | 9 | M16817 | |
| Pathway | REACTOME_TRIGLYCERIDE_BIOSYNTHESIS | 6.33e-06 | 12 | 154 | 4 | MM15447 | |
| Pathway | REACTOME_TRIGLYCERIDE_BIOSYNTHESIS | 1.26e-05 | 14 | 154 | 4 | M619 | |
| Pathway | REACTOME_ACTIVATION_OF_BH3_ONLY_PROTEINS | 1.67e-05 | 30 | 154 | 5 | M17814 | |
| Pathway | WP_CONGENITAL_GENERALIZED_LIPODYSTROPHY | 3.72e-05 | 18 | 154 | 4 | M42546 | |
| Pathway | REACTOME_INTRINSIC_PATHWAY_FOR_APOPTOSIS | 7.05e-05 | 40 | 154 | 5 | MM14473 | |
| Pathway | WP_17P133_YWHAE_COPY_NUMBER_VARIATION | 7.09e-05 | 21 | 154 | 4 | M48088 | |
| Pathway | REACTOME_INTERFERON_GAMMA_SIGNALING | 9.76e-05 | 98 | 154 | 7 | M965 | |
| Pathway | REACTOME_TRIGLYCERIDE_METABOLISM | 1.03e-04 | 23 | 154 | 4 | MM15575 | |
| Pathway | KEGG_LONG_TERM_POTENTIATION | 1.14e-04 | 70 | 154 | 6 | M3115 | |
| Pathway | PID_A6B1_A6B4_INTEGRIN_PATHWAY | 1.39e-04 | 46 | 154 | 5 | M239 | |
| Pathway | PID_LKB1_PATHWAY | 1.54e-04 | 47 | 154 | 5 | M87 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_RETROGRADE_AXONAL_TRANSPORT | 1.98e-04 | 27 | 154 | 4 | M47755 | |
| Pathway | REACTOME_TRANSPORT_OF_ORGANIC_ANIONS | 1.98e-04 | 11 | 154 | 3 | M930 | |
| Pathway | REACTOME_DEPOLYMERIZATION_OF_THE_NUCLEAR_LAMINA | 2.62e-04 | 12 | 154 | 3 | MM15105 | |
| Pathway | REACTOME_SARS_COV_2_TARGETS_HOST_INTRACELLULAR_SIGNALLING_AND_REGULATORY_PATHWAYS | 2.62e-04 | 12 | 154 | 3 | M45022 | |
| Pathway | REACTOME_SYNTHESIS_OF_PE | 2.62e-04 | 12 | 154 | 3 | MM14586 | |
| Pathway | REACTOME_CHK1_CHK2_CDS1_MEDIATED_INACTIVATION_OF_CYCLIN_B_CDK1_COMPLEX | 2.62e-04 | 12 | 154 | 3 | MM15443 | |
| Pathway | REACTOME_TRANSPORT_OF_ORGANIC_ANIONS | 2.62e-04 | 12 | 154 | 3 | MM15476 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN | 2.74e-04 | 53 | 154 | 5 | M27212 | |
| Pathway | REACTOME_INTRINSIC_PATHWAY_FOR_APOPTOSIS | 3.27e-04 | 55 | 154 | 5 | M7455 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN | 3.27e-04 | 55 | 154 | 5 | MM14917 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCV_CORE_TO_ERK_SIGNALING_PATHWAY | 3.37e-04 | 13 | 154 | 3 | M47589 | |
| Pathway | REACTOME_SYNTHESIS_OF_PE | 3.37e-04 | 13 | 154 | 3 | M656 | |
| Pathway | REACTOME_CHK1_CHK2_CDS1_MEDIATED_INACTIVATION_OF_CYCLIN_B_CDK1_COMPLEX | 3.37e-04 | 13 | 154 | 3 | M27708 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | PCSK5 MYO5B TRPC1 PSMB7 SLCO1B3 ADCY9 CLCN2 AP2A1 ABCD3 TRPM1 TRPC7 ABCC11 SLCO1B1 SLC6A6 SLC6A13 SLC16A1 SLCO2A1 SLC22A4 SLC14A2 | 4.23e-04 | 736 | 154 | 19 | M27287 |
| Pathway | REACTOME_RAP1_SIGNALLING | 5.28e-04 | 15 | 154 | 3 | MM15019 | |
| Pathway | REACTOME_DEPOLYMERIZATION_OF_THE_NUCLEAR_LAMINA | 5.28e-04 | 15 | 154 | 3 | M27360 | |
| Pathway | REACTOME_RAP1_SIGNALLING | 6.45e-04 | 16 | 154 | 3 | M923 | |
| Pathway | REACTOME_SARS_COV_1_TARGETS_HOST_INTRACELLULAR_SIGNALLING_AND_REGULATORY_PATHWAYS | 6.45e-04 | 16 | 154 | 3 | M46428 | |
| Pathway | REACTOME_TRIGLYCERIDE_METABOLISM | 7.57e-04 | 38 | 154 | 4 | M27856 | |
| Pathway | REACTOME_METABOLISM_OF_ANGIOTENSINOGEN_TO_ANGIOTENSINS | 7.77e-04 | 17 | 154 | 3 | M27104 | |
| Pubmed | In silico genomic analysis of the human and murine guanylate-binding protein (GBP) gene clusters. | 1.61e-12 | 8 | 219 | 6 | 16689661 | |
| Pubmed | Caspase-11 activation requires lysis of pathogen-containing vacuoles by IFN-induced GTPases. | 4.81e-12 | 9 | 219 | 6 | 24739961 | |
| Pubmed | Unique features of different members of the human guanylate-binding protein family. | 9.46e-12 | 5 | 219 | 5 | 17266443 | |
| Pubmed | 9.46e-12 | 5 | 219 | 5 | 21151871 | ||
| Pubmed | Extensive characterization of IFN-induced GTPases mGBP1 to mGBP10 involved in host defense. | 2.62e-11 | 11 | 219 | 6 | 18025219 | |
| Pubmed | Guanylate binding proteins promote caspase-11-dependent pyroptosis in response to cytoplasmic LPS. | 2.62e-11 | 11 | 219 | 6 | 24715728 | |
| Pubmed | 5.21e-11 | 12 | 219 | 6 | 35906252 | ||
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | SPNS1 TM9SF3 PSMB7 NEDD1 CDKAL1 CKB ACAD11 AP2A1 AGL ABCD3 PLK1 CNP PUS7 DNAJB1 HACD3 POLE ATL3 PRPF8 YWHAG YWHAH YWHAZ PPP5C ATP6AP2 MACO1 AKAP10 ASPRV1 | 6.81e-10 | 974 | 219 | 26 | 28675297 |
| Pubmed | A family of IFN-γ-inducible 65-kD GTPases protects against bacterial infection. | 1.47e-09 | 19 | 219 | 6 | 21551061 | |
| Pubmed | 1.53e-09 | 4 | 219 | 4 | 38404575 | ||
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | PDK2 PDK3 TM9SF3 PSMB7 BIRC6 KBTBD7 ADCY9 CDKAL1 LACTB CKB SENP1 OCIAD1 NDUFAF7 RPTOR PWP2 ABCD3 UQCRB ACOT2 PLK1 CNP TTC28 HACD3 POLE CCDC115 YWHAG YWHAH YWHAZ ATP6AP2 MACO1 KIAA1217 ASS1 LRP2 | 1.57e-09 | 1496 | 219 | 32 | 32877691 |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | HBS1L MYO5B ITGAV NDRG3 CKB BAIAP2L1 C5 BBOX1 MNDA CNP DNAJB1 ANPEP ANXA7 AOX1 ABCC11 YWHAG YWHAH YWHAZ SLC6A13 SLC46A3 IGF2R ATP6AP2 ASS1 LRP2 TMPRSS2 CTSD | 1.64e-09 | 1016 | 219 | 26 | 19056867 |
| Pubmed | 2.92e-09 | 21 | 219 | 6 | 19158679 | ||
| Pubmed | MMS19 assembles iron-sulfur proteins required for DNA metabolism and genomic integrity. | FMNL2 CDKAL1 AP2A1 PWP2 ABCD3 FMNL1 CNP POLE FMNL3 GTF2E2 TYW1 | 3.32e-09 | 150 | 219 | 11 | 22678362 |
| Pubmed | SPNS1 MYO5A RPLP2 PDK3 GTF3C3 ADCY9 CDKAL1 LACTB NCBP3 SENP1 OCIAD1 NF2 PWP2 ABCD3 PUS7 DNAJB1 HACD3 POLE CCDC115 PRPF8 GTF2E2 IGF2R PPP5C SLC16A1 DNAJC15 ATP6AP2 MACO1 LSS CHID1 TYW1 EDRF1 | 5.30e-09 | 1487 | 219 | 31 | 33957083 | |
| Pubmed | HBS1L MYO5A RPLP2 BIRC6 CDKAL1 OCIAD1 AP2A1 NF2 GBP5 EIF3L ABCD3 ATL2 FMNL1 ALOX5AP CNP DOCK9 ANXA7 ATL3 CCDC115 PRPF8 YWHAG IGF2R SLC16A1 LSS EXOC1 CHID1 CNOT1 | 6.76e-09 | 1168 | 219 | 27 | 19946888 | |
| Pubmed | 7.61e-09 | 5 | 219 | 4 | 12396730 | ||
| Pubmed | Essential Role of mGBP7 for Survival of Toxoplasma gondii Infection. | 7.61e-09 | 5 | 219 | 4 | 31964735 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | HBS1L MYO5A RPLP2 BIRC6 GTF3C3 AP2A1 RPTOR RECQL5 EIF3L INTS11 ABCD3 PLK1 YTHDF2 CNP HACD3 POLE ADNP2 ATL3 COPS3 PRPF8 YWHAG YWHAZ SLC16A1 ASS1 AKAP10 EXOC1 DCTN4 CDC27 CTSD | 9.49e-09 | 1353 | 219 | 29 | 29467282 |
| Pubmed | BIRC6 ACAD11 AP2A1 NF2 PLK1 FMNL1 ANKS1A DNAJB1 TTC28 INPP5F THOC2 YWHAG YWHAH YWHAZ ASS1 CNOT1 | 2.91e-08 | 446 | 219 | 16 | 24255178 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | RPLP2 TM9SF3 PSMB7 BIRC6 GTF3C3 CDKAL1 RPTOR AGL ABCD3 PLK1 YTHDF2 CNP DNAJB1 RAP1A RAP1B HACD3 POLE PRPF8 THOC2 YWHAG YWHAH YWHAZ SLC16A1 SMARCB1 DCTN4 CDC27 CNOT1 | 3.09e-08 | 1257 | 219 | 27 | 37317656 |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | MYO5B TM9SF3 NEDD1 ITGAV FMNL2 TTC8 OCIAD1 AP2A1 SERINC1 RPTOR EIF3L ABCD3 PAN2 ATL2 PLK1 CNP DNAJB1 COPS3 PRPF8 LPIN3 EXOC1 DCTN4 CDC27 CNOT1 EDRF1 WDTC1 LARGE1 | 8.43e-08 | 1321 | 219 | 27 | 27173435 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | MYO5A MYO5B RPLP2 TM9SF3 GTF3C3 LACTB AP2A1 BAIAP2L1 EIF3L PWP2 ABCD3 YTHDF2 CNP RAP1B HACD3 LAMA3 PRPF8 THOC2 YWHAG YWHAH YWHAZ SLC16A1 PHF3 KIAA1217 ASS1 CTSD | 1.19e-07 | 1257 | 219 | 26 | 36526897 |
| Pubmed | TM9SF3 BIRC6 ADCY9 CDKAL1 YIF1A SENP1 EIF3L PWP2 ACOT2 ATL2 CNP RAP1B HACD3 ATL3 PRPF8 YWHAH YWHAZ SLC6A6 IGF2R SLC16A1 MACO1 TYW1 | 1.87e-07 | 952 | 219 | 22 | 38569033 | |
| Pubmed | Osteoclast fusion and bone loss are restricted by interferon inducible guanylate binding proteins. | 1.88e-07 | 9 | 219 | 4 | 33479228 | |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | EPHB2 HIF1A RPLP2 TM9SF3 ITGAV GTF3C3 YIF1A SENP1 AP2A1 SP140L RPTOR EIF3L ABCD3 ATL2 ANAPC4 HACD3 ATL3 PRPF8 THOC2 IGF2R SLC16A1 PHF3 ATP6AP2 LSS CNOT1 | 1.94e-07 | 1203 | 219 | 25 | 29180619 |
| Pubmed | Temporal and spatial regulation of the phosphatidate phosphatases lipin 1 and 2. | 2.46e-07 | 3 | 219 | 3 | 18694939 | |
| Pubmed | 2.46e-07 | 3 | 219 | 3 | 32620042 | ||
| Pubmed | 2.46e-07 | 3 | 219 | 3 | 29089068 | ||
| Pubmed | Two families of GTPases dominate the complex cellular response to IFN-gamma. | 2.46e-07 | 3 | 219 | 3 | 9862701 | |
| Pubmed | 2.46e-07 | 3 | 219 | 3 | 11726669 | ||
| Pubmed | GBP2 inhibits pathological angiogenesis in the retina via the AKT/mTOR/VEGFA axis. | 2.46e-07 | 3 | 219 | 3 | 38636926 | |
| Pubmed | 2.46e-07 | 3 | 219 | 3 | 20950129 | ||
| Pubmed | 2.46e-07 | 3 | 219 | 3 | 20735359 | ||
| Pubmed | 2.46e-07 | 3 | 219 | 3 | 32354743 | ||
| Pubmed | Study of LPIN1, LPIN2 and LPIN3 in rhabdomyolysis and exercise-induced myalgia. | 2.46e-07 | 3 | 219 | 3 | 22481384 | |
| Pubmed | GBP3 promotes glioblastoma resistance to temozolomide by enhancing DNA damage repair. | 2.46e-07 | 3 | 219 | 3 | 35780181 | |
| Pubmed | Domain motions, dimerization, and membrane interactions of the murine guanylate binding protein 2. | 2.46e-07 | 3 | 219 | 3 | 36639389 | |
| Pubmed | Three mammalian lipins act as phosphatidate phosphatases with distinct tissue expression patterns. | 2.46e-07 | 3 | 219 | 3 | 17158099 | |
| Pubmed | 2.46e-07 | 3 | 219 | 3 | 16914101 | ||
| Pubmed | GBP3 promotes glioma cell proliferation via SQSTM1/p62-ERK1/2 axis. | 2.46e-07 | 3 | 219 | 3 | 29128363 | |
| Pubmed | 2.46e-07 | 3 | 219 | 3 | 10884287 | ||
| Pubmed | Identification of lipidomic profiles associated with drug-resistant prostate cancer cells. | 2.46e-07 | 3 | 219 | 3 | 33596934 | |
| Pubmed | GTPase properties of the interferon-induced human guanylate-binding protein 2. | 2.46e-07 | 3 | 219 | 3 | 8706832 | |
| Pubmed | 2.46e-07 | 3 | 219 | 3 | 1715024 | ||
| Pubmed | 2.46e-07 | 3 | 219 | 3 | 15717119 | ||
| Pubmed | 2.46e-07 | 3 | 219 | 3 | 35383115 | ||
| Pubmed | 2.46e-07 | 3 | 219 | 3 | 30062052 | ||
| Pubmed | 2.46e-07 | 3 | 219 | 3 | 30507612 | ||
| Pubmed | 2.46e-07 | 3 | 219 | 3 | 26416908 | ||
| Pubmed | Identification and characterization of human FMNL1, FMNL2 and FMNL3 genes in silico. | 2.46e-07 | 3 | 219 | 3 | 12684686 | |
| Pubmed | Murine guanylate binding protein 2 (mGBP2) controls Toxoplasma gondii replication. | 2.46e-07 | 3 | 219 | 3 | 23248289 | |
| Pubmed | 2.46e-07 | 3 | 219 | 3 | 24634820 | ||
| Pubmed | 2.46e-07 | 3 | 219 | 3 | 22730319 | ||
| Pubmed | ACADL MYO5A PDK2 PDK3 ANXA8L1 NDRG3 BIRC6 RPTOR ABCD3 UQCRB RAP1A HACD3 DOCK9 ANXA8 YWHAG YWHAH YWHAZ PPP3R1 PPP5C SLC16A1 KIAA1217 EXOC1 CNOT1 NDRG4 | 2.70e-07 | 1139 | 219 | 24 | 36417873 | |
| Pubmed | HBS1L RPLP2 PDK3 PSMB7 GTF3C3 LACTB CKB AP2A1 EIF3L ABCD3 PLK1 ANAPC4 DNAJB1 KBTBD6 HACD3 COPS3 PRPF8 LMOD2 YWHAG YWHAH YWHAZ PARS2 PPP5C SLC16A1 SMARCB1 CDC27 | 3.75e-07 | 1335 | 219 | 26 | 29229926 | |
| Pubmed | IRGB10 Liberates Bacterial Ligands for Sensing by the AIM2 and Caspase-11-NLRP3 Inflammasomes. | 4.88e-07 | 11 | 219 | 4 | 27693356 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | RPLP2 BAIAP2L1 RPTOR PLK1 YTHDF2 ANKS1A DNAJB1 TTC28 INPP5F DNAH7 YWHAG YWHAH YWHAZ LPIN3 SLC16A1 PHF3 KIAA1217 ASS1 PRRC1 EDRF1 | 6.40e-07 | 861 | 219 | 20 | 36931259 |
| Pubmed | 7.28e-07 | 12 | 219 | 4 | 29459437 | ||
| Pubmed | HIF1A KBTBD7 GTF3C3 BAIAP2L1 RPTOR AGL ABCD3 PLK1 DNAJB1 KBTBD6 HACD3 YWHAH PARS2 WDTC1 | 8.43e-07 | 437 | 219 | 14 | 20562859 | |
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | 9.05e-07 | 208 | 219 | 10 | 33230847 | |
| Pubmed | Characterisation of the expression of NMDA receptors in human astrocytes. | 9.81e-07 | 4 | 219 | 3 | 21152063 | |
| Pubmed | 9.81e-07 | 4 | 219 | 3 | 11138012 | ||
| Pubmed | 9.81e-07 | 4 | 219 | 3 | 39337476 | ||
| Pubmed | Interferon regulatory factor 1 is required for mouse Gbp gene activation by gamma interferon. | 9.81e-07 | 4 | 219 | 3 | 7823961 | |
| Pubmed | 9.81e-07 | 4 | 219 | 3 | 36609599 | ||
| Pubmed | 9.81e-07 | 4 | 219 | 3 | 10386861 | ||
| Pubmed | 9.81e-07 | 4 | 219 | 3 | 8917111 | ||
| Pubmed | RPLP2 PSMB7 GTF3C3 CKB ACAD11 SERINC1 EIF3L PWP2 UQCRB PLK1 YTHDF2 ANAPC4 DNAJB1 RAP1B HACD3 PRPF8 YWHAG YWHAH YWHAZ SLC6A6 CDC27 | 1.04e-06 | 971 | 219 | 21 | 33306668 | |
| Pubmed | RPLP2 SIDT1 GTF3C3 CKB BAIAP2L1 EIF3L ABCD3 PLK1 HACD3 PRPF8 THOC2 YWHAG YWHAH YWHAZ IGF2R SLC16A1 EXOC1 CDC27 CNOT1 | 1.05e-06 | 809 | 219 | 19 | 32129710 | |
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | MYO5B PDK3 GTF3C3 PLK1 YTHDF2 CNP POLE COPS3 PRPF8 THOC2 YWHAG YWHAH YWHAZ PPP3CC SLC16A1 PHF3 | 1.06e-06 | 583 | 219 | 16 | 29844126 |
| Pubmed | ERICH1 NEDD1 BIRC6 ADCY9 CDKAL1 OCIAD1 EIF3L CHD6 ATL2 YTHDF2 ANKS1A TTC28 SLC6A6 IGF2R PHF3 MACO1 TYW1 PRRC1 | 1.09e-06 | 733 | 219 | 18 | 34672954 | |
| Pubmed | Phospho-proteomic analyses of B-Raf protein complexes reveal new regulatory principles. | 1.59e-06 | 89 | 219 | 7 | 27034005 | |
| Pubmed | OTUB2 Promotes Cancer Metastasis via Hippo-Independent Activation of YAP and TAZ. | 1.84e-06 | 91 | 219 | 7 | 30472188 | |
| Pubmed | 1.98e-06 | 15 | 219 | 4 | 17114464 | ||
| Pubmed | 1.98e-06 | 15 | 219 | 4 | 25774716 | ||
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | EPHB2 OCIAD1 AP2A1 BAIAP2L1 AGL UQCRB ATL2 CNP PUS7 DNAJB1 RAP1B ANXA7 ATL3 COPS3 PRPF8 YWHAG YWHAH YWHAZ SERPINA12 IGF2R PPP5C SLC16A1 EXOC1 CDC27 CNOT1 | 1.98e-06 | 1367 | 219 | 25 | 32687490 |
| Pubmed | 2.24e-06 | 230 | 219 | 10 | 35449600 | ||
| Pubmed | MYO5A ASH1L NUP58 FMNL2 AP2A1 FCGR1A NF2 CHD6 ZNF841 EGLN2 SGTB TTC28 ANXA7 ADNP2 GRIK1 PRPF8 YWHAG YWHAH YWHAZ PPP3R1 PPP5C LRP2 MAST1 EXOC1 | 2.25e-06 | 1285 | 219 | 24 | 35914814 | |
| Pubmed | Rap1 promotes VEGFR2 activation and angiogenesis by a mechanism involving integrin αvβ₃. | 2.44e-06 | 5 | 219 | 3 | 21636859 | |
| Pubmed | TCR Affinity Biases Th Cell Differentiation by Regulating CD25, Eef1e1, and Gbp2. | 2.44e-06 | 5 | 219 | 3 | 30858199 | |
| Pubmed | Murine GBP-2: a new IFN-gamma-induced member of the GBP family of GTPases isolated from macrophages. | 2.44e-06 | 5 | 219 | 3 | 9858320 | |
| Pubmed | DCDC1 ASH1L FMNL2 ADCY9 CDKAL1 SENP1 ACAD11 RPTOR INTS11 ANAPC4 TTC28 AOX1 ADNP2 YWHAH PARS2 SLC16A1 ASS1 LRP2 SMARCB1 CDC27 WDTC1 SP140 | 2.59e-06 | 1116 | 219 | 22 | 31753913 | |
| Pubmed | Localization of Xenobiotic Transporters Expressed at the Human Blood-Testis Barrier. | 2.62e-06 | 16 | 219 | 4 | 35307651 | |
| Pubmed | HBS1L SPNS1 RPLP2 NEDD1 ITGAV BIRC6 CKB AP2A1 EIF3L YTHDF2 CNP RAP1A ANXA7 PRPF8 YWHAG YWHAZ IGF2R ATP6AP2 ASS1 SMARCB1 CHID1 CDC27 CTSD CNOT1 | 2.64e-06 | 1297 | 219 | 24 | 33545068 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | HIF1A MYO5A ASH1L LHPP NEDD1 TTC8 SENP1 NF2 RPTOR CHD6 ANKS1A RAP1A HACD3 ANXA7 LAMA3 GRIK1 SLC25A36 PCNX4 KIAA1217 ASS1 MAST1 ZFHX2 TMPRSS2 LSS CATSPERG CNOT1 | 2.82e-06 | 1489 | 219 | 26 | 28611215 |
| Pubmed | HBS1L TM9SF3 ADCY9 CDKAL1 BAIAP2L1 ABCD3 YTHDF2 CNP ANKS1A DNAJB1 TTC28 HACD3 YWHAG IGF2R SLC16A1 CDC27 CNOT1 | 2.95e-06 | 708 | 219 | 17 | 39231216 | |
| Pubmed | 3.41e-06 | 17 | 219 | 4 | 24086760 | ||
| Pubmed | 3.41e-06 | 17 | 219 | 4 | 25774715 | ||
| Pubmed | TM9SF3 ADCY9 CDKAL1 AP2A1 ATL2 HACD3 ATL3 CCDC115 ATP6AP2 MACO1 TYW1 | 3.50e-06 | 299 | 219 | 11 | 37931956 | |
| Pubmed | PSMB7 ITGAV KBTBD7 NF2 NDUFAF7 PLCB3 PLK1 CNP ANPEP HACD3 GRIK1 CCDC115 DNAH12 LARGE1 | 3.68e-06 | 496 | 219 | 14 | 31343991 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | TOPAZ1 NCBP3 PLK1 ANAPC4 DOCK9 ANXA7 COPS3 PRPF8 DNAI1 LOXHD1 DNAH12 ASS1 SMARCB1 CNOT1 | 3.76e-06 | 497 | 219 | 14 | 36774506 |
| Pubmed | 3.86e-06 | 66 | 219 | 6 | 23275444 | ||
| Pubmed | HAPSTR1 localizes HUWE1 to the nucleus to limit stress signaling pathways. | HBS1L BIRC6 GTF3C3 CKB OCIAD1 RPTOR EIF3L YTHDF2 CNP HACD3 COPS3 IGF2R SLC16A1 CTSD WDTC1 | 3.93e-06 | 571 | 219 | 15 | 37167062 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | HBS1L RPLP2 TRPC1 TM9SF3 GTF3C3 CKB AP2A1 RPTOR EIF3L INTS11 PWP2 ABCD3 ATL2 DNAJB1 RAP1B HACD3 POLE COPS3 PRPF8 THOC2 IGF2R PPP5C SLC16A1 CTSD CNOT1 | 4.10e-06 | 1425 | 219 | 25 | 30948266 |
| Pubmed | Serine Phosphorylation by mTORC1 Promotes IRS-1 Degradation through SCFβ-TRCP E3 Ubiquitin Ligase. | 4.37e-06 | 18 | 219 | 4 | 30240640 | |
| Pubmed | Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma. | CKB NF2 EIF3L ABCD3 C5 YTHDF2 ANXA7 LAMA3 ANXA8 PRPF8 YWHAG SERPINA12 MACO1 KIAA1217 ASPRV1 CNOT1 PRRC1 | 4.58e-06 | 732 | 219 | 17 | 34732716 |
| Pubmed | 4.86e-06 | 6 | 219 | 3 | 16672277 | ||
| Pubmed | 4.86e-06 | 6 | 219 | 3 | 17293456 | ||
| Pubmed | 4.86e-06 | 6 | 219 | 3 | 21757726 | ||
| Interaction | KLHDC2 interactions | 8.76e-08 | 76 | 208 | 9 | int:KLHDC2 | |
| Interaction | RAB35 interactions | EPHB2 MYO5A NDRG3 FMNL2 ADCY9 CDKAL1 OCIAD1 NF2 BAIAP2L1 ABCD3 PLK1 CNP DNAJB1 RAP1A RAP1B DOCK9 INPP5F IGF2R SLC16A1 ATP6AP2 MACO1 LRP2 | 1.31e-07 | 573 | 208 | 22 | int:RAB35 |
| Interaction | RAC2 interactions | TM9SF3 ITGAV ADCY9 CDKAL1 SENP1 OCIAD1 NF2 BAIAP2L1 ABCD3 PLCB3 FMNL1 RAP1B HACD3 DOCK9 CCDC115 YWHAG FMNL3 SLC6A6 IGF2R SLC16A1 ATP6AP2 MACO1 SLC22A4 TYW1 | 1.37e-07 | 674 | 208 | 24 | int:RAC2 |
| Interaction | RHOD interactions | MYO5A ITGAV FMNL2 ADCY9 CDKAL1 SENP1 NF2 BAIAP2L1 ABCD3 FMNL1 PUS7 RAP1B HACD3 DOCK9 CCDC115 SLC6A6 IGF2R SLC16A1 ATP6AP2 MACO1 SLC22A4 | 5.35e-07 | 572 | 208 | 21 | int:RHOD |
| Interaction | MTMR3 interactions | 6.14e-07 | 70 | 208 | 8 | int:MTMR3 | |
| Interaction | LPIN3 interactions | 8.51e-07 | 73 | 208 | 8 | int:LPIN3 | |
| Interaction | KCNA3 interactions | HBS1L TM9SF3 ADCY9 CDKAL1 CKB NF2 BAIAP2L1 RPTOR ABCD3 TRPM1 YTHDF2 CNP ANKS1A DNAJB1 TTC28 HACD3 THOC2 HELQ YWHAG IGF2R SLC16A1 PHF3 LRP2 CDC27 CNOT1 | 3.85e-06 | 871 | 208 | 25 | int:KCNA3 |
| Interaction | LNP1 interactions | 5.01e-06 | 25 | 208 | 5 | int:LNP1 | |
| Interaction | CDC42 interactions | RPLP2 TM9SF3 ITGAV FMNL2 ADCY9 CDKAL1 YIF1A SENP1 NF2 BAIAP2L1 ABCD3 FMNL1 CNP FGD3 RAP1A RAP1B HACD3 DOCK9 ATL3 CCDC115 YWHAG YWHAH FMNL3 SLC6A6 IGF2R SLC16A1 ATP6AP2 MACO1 SLC22A4 LRP2 TYW1 CNOT1 | 5.85e-06 | 1323 | 208 | 32 | int:CDC42 |
| Interaction | RHOA interactions | SPNS1 TRPC1 TM9SF3 ITGAV FMNL2 ADCY9 CDKAL1 YIF1A SENP1 OCIAD1 BAIAP2L1 ABCD3 ATL2 FMNL1 CNP RAP1B HACD3 ATL3 CCDC115 YWHAG FMNL3 IGF2R SLC16A1 ATP6AP2 MACO1 SLC22A4 LRP2 TMPRSS2 TYW1 PRRC1 | 6.14e-06 | 1199 | 208 | 30 | int:RHOA |
| Interaction | GRID2IP interactions | 7.33e-06 | 13 | 208 | 4 | int:GRID2IP | |
| Interaction | HECTD1 interactions | EPHB2 HBS1L HIF1A MYO5A PDK3 BIRC6 GTF3C3 NCBP3 ACAD11 AP2A1 NF2 PWP2 PLK1 YTHDF2 TTC28 HACD3 POLE PRPF8 THOC2 YWHAG YWHAH YWHAZ PHF3 EXOC1 CDC27 CNOT1 | 1.06e-05 | 984 | 208 | 26 | int:HECTD1 |
| Interaction | LAMP1 interactions | MYO5A ITGAV ADCY9 CDKAL1 AP2A1 NF2 BAIAP2L1 RPTOR PLCB3 CNP HACD3 INPP5F CCDC115 YWHAH PARS2 IGF2R SLC16A1 ATP6AP2 TMPRSS2 CTSD | 1.24e-05 | 644 | 208 | 20 | int:LAMP1 |
| Interaction | LAMP3 interactions | HBS1L MYO5A FMNL2 ADCY9 CDKAL1 YIF1A CNP SGTB TTC28 ATL3 INPP5F SLC6A6 IGF2R ATP6AP2 MACO1 LRP2 AKAP10 | 1.27e-05 | 486 | 208 | 17 | int:LAMP3 |
| Interaction | STIM1 interactions | EPHB2 TRPC1 ADCY9 CDKAL1 PLK1 YWHAG YWHAH YWHAZ PARS2 IGF2R ATP6AP2 MACO1 SLC22A4 LRP2 TYW1 | 1.31e-05 | 388 | 208 | 15 | int:STIM1 |
| Interaction | RAP1GAP interactions | 1.38e-05 | 51 | 208 | 6 | int:RAP1GAP | |
| Interaction | LPIN1 interactions | 1.52e-05 | 31 | 208 | 5 | int:LPIN1 | |
| Interaction | MAP3K9 interactions | 1.52e-05 | 31 | 208 | 5 | int:MAP3K9 | |
| Interaction | GBP2 interactions | 1.92e-05 | 54 | 208 | 6 | int:GBP2 | |
| Interaction | MMS19 interactions | HIF1A FMNL2 CDKAL1 AP2A1 PWP2 ABCD3 FMNL1 CNP POLE FMNL3 GTF2E2 TYW1 WDTC1 | 2.23e-05 | 311 | 208 | 13 | int:MMS19 |
| Interaction | RAB11FIP2 interactions | 2.41e-05 | 83 | 208 | 7 | int:RAB11FIP2 | |
| Interaction | RAC3 interactions | ITGAV ADCY9 CDKAL1 SENP1 NF2 BAIAP2L1 ABCD3 ANKS1A RAP1B HACD3 DOCK9 CCDC115 YWHAG YWHAZ IGF2R ATP6AP2 MACO1 KIAA1217 SLC22A4 | 2.42e-05 | 619 | 208 | 19 | int:RAC3 |
| Interaction | PACS1 interactions | 2.63e-05 | 57 | 208 | 6 | int:PACS1 | |
| Interaction | FAM86C1P interactions | 2.82e-05 | 35 | 208 | 5 | int:FAM86C1P | |
| Interaction | RGL1 interactions | 3.01e-05 | 18 | 208 | 4 | int:RGL1 | |
| Interaction | ARF6 interactions | EPHB2 SPNS1 TM9SF3 FMNL2 ADCY9 CDKAL1 OCIAD1 AP2A1 BAIAP2L1 ABCD3 ACOT2 PLK1 CNP RAP1B DNAH7 IGF2R SLC16A1 ATP6AP2 | 3.78e-05 | 584 | 208 | 18 | int:ARF6 |
| Interaction | CRTC2 interactions | 3.89e-05 | 61 | 208 | 6 | int:CRTC2 | |
| Interaction | MTMR4 interactions | 3.98e-05 | 158 | 208 | 9 | int:MTMR4 | |
| Interaction | PFKFB4 interactions | 4.25e-05 | 38 | 208 | 5 | int:PFKFB4 | |
| Interaction | ESYT1 interactions | TM9SF3 FMNL2 ADCY9 CDKAL1 AP2A1 RPTOR ATL2 ATL3 CCDC115 YWHAG YWHAH YWHAZ ATP6AP2 MACO1 TMPRSS2 | 4.42e-05 | 431 | 208 | 15 | int:ESYT1 |
| Interaction | TMCC3 interactions | 4.83e-05 | 39 | 208 | 5 | int:TMCC3 | |
| Interaction | DCLK1 interactions | 5.28e-05 | 127 | 208 | 8 | int:DCLK1 | |
| Interaction | FAM117B interactions | 5.47e-05 | 40 | 208 | 5 | int:FAM117B | |
| Interaction | DENND1B interactions | 5.75e-05 | 21 | 208 | 4 | int:DENND1B | |
| Interaction | KCNK15 interactions | 5.84e-05 | 8 | 208 | 3 | int:KCNK15 | |
| Interaction | RHOB interactions | EPHB2 TM9SF3 ASH1L ITGAV FMNL2 ADCY9 CKB NF2 BAIAP2L1 PLK1 FMNL1 CNP RAP1A RAP1B HACD3 DOCK9 YWHAG SLC6A6 IGF2R SLC16A1 SLC22A4 CDC27 | 6.06e-05 | 840 | 208 | 22 | int:RHOB |
| Interaction | BRD1 interactions | CDKAL1 RPTOR INTS11 ANAPC4 YWHAG YWHAH YWHAZ PARS2 PPP5C ASS1 LRP2 CDC27 WDTC1 | 6.29e-05 | 344 | 208 | 13 | int:BRD1 |
| Interaction | RIPK4 interactions | RPLP2 GTF3C3 CDKAL1 SENP1 NF2 ABCD3 CNP DNAJB1 POLE YWHAG YWHAH YWHAZ PPP5C SLC16A1 SLC22A4 | 6.50e-05 | 446 | 208 | 15 | int:RIPK4 |
| Interaction | GBP1 interactions | 6.96e-05 | 42 | 208 | 5 | int:GBP1 | |
| Interaction | RHOF interactions | MYO5A TM9SF3 ITGAV ADCY9 SENP1 NF2 BAIAP2L1 PLCB3 FMNL1 RAP1B HACD3 DOCK9 ATL3 CCDC115 SLC6A6 IGF2R SLC16A1 ATP6AP2 SLC22A4 | 7.44e-05 | 673 | 208 | 19 | int:RHOF |
| Interaction | MAP3K15 interactions | 8.37e-05 | 23 | 208 | 4 | int:MAP3K15 | |
| Interaction | KCNK9 interactions | 8.70e-05 | 9 | 208 | 3 | int:KCNK9 | |
| Interaction | RHOH interactions | SPNS1 MYO5A TM9SF3 ITGAV ADCY9 CDKAL1 BAIAP2L1 ABCD3 FMNL1 CNP RAP1B HACD3 INPP5F CCDC115 IGF2R SLC22A4 | 8.79e-05 | 512 | 208 | 16 | int:RHOH |
| Interaction | UNK interactions | BIRC6 OCIAD1 SERINC1 RPTOR ABCD3 YTHDF2 RAP1A COPS3 YWHAG YWHAZ SLC16A1 ATP6AP2 MACO1 CNOT1 | 9.24e-05 | 408 | 208 | 14 | int:UNK |
| Interaction | LPIN2 interactions | 9.96e-05 | 24 | 208 | 4 | int:LPIN2 | |
| Interaction | RAC1 interactions | MYO5B TM9SF3 ITGAV FMNL2 ADCY9 SENP1 OCIAD1 NF2 BAIAP2L1 PLCB3 FMNL1 CNP ANKS1A RAP1B HACD3 DOCK9 CCDC115 YWHAG YWHAZ SLC6A6 IGF2R SLC16A1 ATP6AP2 SLC22A4 LRP2 | 1.06e-04 | 1063 | 208 | 25 | int:RAC1 |
| Interaction | MEX3B interactions | 1.08e-04 | 222 | 208 | 10 | int:MEX3B | |
| Interaction | CPAP interactions | 1.19e-04 | 182 | 208 | 9 | int:CPAP | |
| Interaction | RASSF2 interactions | 1.20e-04 | 47 | 208 | 5 | int:RASSF2 | |
| Interaction | OTOG interactions | 1.23e-04 | 10 | 208 | 3 | int:OTOG | |
| Interaction | GBP3 interactions | 1.23e-04 | 10 | 208 | 3 | int:GBP3 | |
| Interaction | KSR2 interactions | 1.33e-04 | 48 | 208 | 5 | int:KSR2 | |
| Interaction | NUP155 interactions | NUP58 KBTBD7 ADCY9 CDKAL1 YIF1A SENP1 OCIAD1 ABCD3 PLK1 PRPF8 IGF2R ATP6AP2 MACO1 CNOT1 WDTC1 | 1.37e-04 | 477 | 208 | 15 | int:NUP155 |
| Interaction | MAST4 interactions | 1.38e-04 | 26 | 208 | 4 | int:MAST4 | |
| Interaction | PARD6B interactions | 1.40e-04 | 146 | 208 | 8 | int:PARD6B | |
| Interaction | RAB11A interactions | MYO5A MYO5B BIRC6 ADCY9 CDKAL1 OCIAD1 BAIAP2L1 ABCD3 FMNL1 CNP RAP1B INPP5F YWHAG IGF2R SLC16A1 ATP6AP2 MACO1 LRP2 AKAP10 EXOC1 DCTN4 | 1.45e-04 | 830 | 208 | 21 | int:RAB11A |
| Interaction | TRAK1 interactions | 1.45e-04 | 77 | 208 | 6 | int:TRAK1 | |
| Interaction | ANAPC2 interactions | 1.66e-04 | 234 | 208 | 10 | int:ANAPC2 | |
| Interaction | CDCA7 interactions | 1.68e-04 | 11 | 208 | 3 | int:CDCA7 | |
| Interaction | ZNF135 interactions | 1.68e-04 | 11 | 208 | 3 | int:ZNF135 | |
| Interaction | RAB5C interactions | ADCY9 CDKAL1 YIF1A OCIAD1 ABCD3 DNAJB1 RAP1A RAP1B ATL3 INPP5F SLC6A6 IGF2R SLC16A1 ATP6AP2 MACO1 LRP2 WDTC1 | 1.72e-04 | 600 | 208 | 17 | int:RAB5C |
| Interaction | STX7 interactions | MYO5A ADCY9 CDKAL1 NF2 BAIAP2L1 CNP RAP1A RAP1B INPP5F SLC6A6 GTF2E2 IGF2R SLC16A1 ATP6AP2 MACO1 SLC22A4 LRP2 TMPRSS2 | 1.74e-04 | 659 | 208 | 18 | int:STX7 |
| Interaction | SPATA18 interactions | 1.86e-04 | 28 | 208 | 4 | int:SPATA18 | |
| Interaction | RHOQ interactions | MYO5A ITGAV ADCY9 NF2 BAIAP2L1 RPTOR CNP RAP1B DOCK9 INPP5F YWHAZ IGF2R SLC16A1 LRP2 | 2.12e-04 | 442 | 208 | 14 | int:RHOQ |
| Interaction | SYNE3 interactions | TOGARAM1 NUP58 NEDD1 KBTBD7 ADCY9 CDKAL1 SENP1 PLK1 IGF2R MACO1 KIAA1217 CHID1 TYW1 CNOT1 | 2.22e-04 | 444 | 208 | 14 | int:SYNE3 |
| Interaction | PPP1R3E interactions | 2.23e-04 | 12 | 208 | 3 | int:PPP1R3E | |
| Interaction | C9orf72 interactions | RPLP2 TM9SF3 PSMB7 BIRC6 GTF3C3 CDKAL1 OCIAD1 RPTOR AGL ABCD3 PLK1 YTHDF2 CNP DNAJB1 RAP1A RAP1B HACD3 POLE PRPF8 THOC2 YWHAG YWHAH YWHAZ SLC16A1 SMARCB1 DCTN4 CDC27 CNOT1 | 2.25e-04 | 1319 | 208 | 28 | int:C9orf72 |
| Interaction | OSBPL6 interactions | 2.34e-04 | 84 | 208 | 6 | int:OSBPL6 | |
| Interaction | ATG5 interactions | MYO5A GBP1 AP2A1 NF2 AGL CNP PUS7 DNAJB1 TTC28 DOCK9 YWHAZ IGF2R | 2.53e-04 | 344 | 208 | 12 | int:ATG5 |
| Interaction | VIM interactions | PSMB7 LHPP NEDD1 OCIAD1 CLCN2 RPTOR PAN2 PLK1 ANXA7 ADNP2 PRPF8 THOC2 YWHAG YWHAH YWHAZ PPP5C TIMP3 ATP6AP2 KIAA1217 SMARCB1 | 2.61e-04 | 804 | 208 | 20 | int:VIM |
| Interaction | GPBP1L1 interactions | 2.66e-04 | 86 | 208 | 6 | int:GPBP1L1 | |
| Interaction | PABIR1 interactions | 2.79e-04 | 31 | 208 | 4 | int:PABIR1 | |
| Interaction | CRTC1 interactions | 2.79e-04 | 31 | 208 | 4 | int:CRTC1 | |
| Interaction | KCNK3 interactions | 2.87e-04 | 13 | 208 | 3 | int:KCNK3 | |
| Interaction | TPH1 interactions | 2.87e-04 | 13 | 208 | 3 | int:TPH1 | |
| Interaction | PPM1H interactions | 2.91e-04 | 123 | 208 | 7 | int:PPM1H | |
| Interaction | CFAP97 interactions | 3.02e-04 | 57 | 208 | 5 | int:CFAP97 | |
| Interaction | FOXO3 interactions | 3.06e-04 | 124 | 208 | 7 | int:FOXO3 | |
| Interaction | HAX1 interactions | ADCY9 CDKAL1 LACTB CKB OCIAD1 ABCD3 DNAJB1 POLE PPP3CC PPP3R1 DNAJC15 AKAP10 NDRG4 | 3.07e-04 | 404 | 208 | 13 | int:HAX1 |
| Interaction | AKT1S1 interactions | 3.16e-04 | 32 | 208 | 4 | int:AKT1S1 | |
| Interaction | CEP85L interactions | 3.57e-04 | 33 | 208 | 4 | int:CEP85L | |
| Interaction | RHOC interactions | ITGAV FMNL2 ADCY9 CDKAL1 BAIAP2L1 ABCD3 CNP RAP1B HACD3 CCDC115 YWHAG IGF2R SLC16A1 ATP6AP2 MACO1 SLC22A4 | 3.88e-04 | 584 | 208 | 16 | int:RHOC |
| Interaction | TPTE interactions | 3.89e-04 | 129 | 208 | 7 | int:TPTE | |
| Interaction | BAIAP2L1 interactions | 3.89e-04 | 129 | 208 | 7 | int:BAIAP2L1 | |
| Interaction | HSP90AB1 interactions | HIF1A PDK2 PDK3 GBP2 LHPP CKB RPTOR PAN2 DNAJB1 LAMA3 COPS3 PRPF8 THOC2 YWHAG YWHAH YWHAZ GTF2E2 IGF2R PPP5C MAST1 EDRF1 WDTC1 | 4.00e-04 | 960 | 208 | 22 | int:HSP90AB1 |
| Interaction | C19orf47 interactions | 4.01e-04 | 34 | 208 | 4 | int:C19orf47 | |
| Interaction | CA9 interactions | 4.09e-04 | 215 | 208 | 9 | int:CA9 | |
| Interaction | LGR4 interactions | 4.10e-04 | 262 | 208 | 10 | int:LGR4 | |
| Interaction | CUL9 interactions | 4.11e-04 | 171 | 208 | 8 | int:CUL9 | |
| Interaction | KSR1 interactions | 4.47e-04 | 132 | 208 | 7 | int:KSR1 | |
| Interaction | TRPM7 interactions | 4.47e-04 | 132 | 208 | 7 | int:TRPM7 | |
| Interaction | DNAH7 interactions | 4.50e-04 | 15 | 208 | 3 | int:DNAH7 | |
| Interaction | ARIH1 interactions | HBS1L BIRC6 KBTBD7 ACAD11 AP2A1 EIF3L APPBP2 KBTBD6 POLE PRPF8 | 4.62e-04 | 266 | 208 | 10 | int:ARIH1 |
| Interaction | ATP2A1 interactions | TM9SF3 ITGAV ADCY9 CDKAL1 YIF1A AP2A1 ABCD3 ATL2 HACD3 IGF2R ATP6AP2 MACO1 TYW1 | 4.74e-04 | 423 | 208 | 13 | int:ATP2A1 |
| Interaction | HUWE1 interactions | HBS1L PSMB7 BIRC6 GTF3C3 CKB OCIAD1 NF2 RPTOR EIF3L YTHDF2 CNP DNAJB1 HACD3 COPS3 PRPF8 YWHAG YWHAH YWHAZ IGF2R PPP5C SLC16A1 TMPRSS2 CTSD WDTC1 | 5.01e-04 | 1110 | 208 | 24 | int:HUWE1 |
| Interaction | SIK1 interactions | 5.19e-04 | 64 | 208 | 5 | int:SIK1 | |
| Interaction | LIMA1 interactions | MYO5A MYO5B AP2A1 RPTOR PAN2 FMNL1 RAP1A RAP1B PRPF8 YWHAG YWHAH YWHAZ LPIN3 | 5.41e-04 | 429 | 208 | 13 | int:LIMA1 |
| Interaction | SAMSN1 interactions | 5.50e-04 | 16 | 208 | 3 | int:SAMSN1 | |
| Interaction | TESPA1 interactions | 5.50e-04 | 16 | 208 | 3 | int:TESPA1 | |
| Interaction | INPP5E interactions | 5.58e-04 | 65 | 208 | 5 | int:INPP5E | |
| Cytoband | 1p22.2 | 4.01e-09 | 28 | 221 | 6 | 1p22.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q11 | SPDYE11 SPDYE13 SPDYE15 SPDYE14 SPDYE17 SPDYE10 SPDYE9 SPDYE12 YWHAG SPDYE8 TYW1 | 9.92e-08 | 271 | 221 | 11 | chr7q11 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p22 | 5.65e-05 | 137 | 221 | 6 | chr1p22 | |
| Cytoband | 7q11.23 | 1.11e-04 | 97 | 221 | 5 | 7q11.23 | |
| Cytoband | 22q12.3 | 5.40e-04 | 33 | 221 | 3 | 22q12.3 | |
| GeneFamily | Lipins | 5.38e-07 | 3 | 148 | 3 | 1043 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 4.71e-06 | 115 | 148 | 8 | 769 | |
| GeneFamily | 14-3-3 phospho-serine/phospho-threonine binding proteins | 1.84e-05 | 7 | 148 | 3 | 1053 | |
| GeneFamily | Annexins|Endogenous ligands | 1.45e-04 | 13 | 148 | 3 | 404 | |
| GeneFamily | Myosins, class V | 1.99e-04 | 3 | 148 | 2 | 1100 | |
| GeneFamily | Dyneins, axonemal | 3.36e-04 | 17 | 148 | 3 | 536 | |
| GeneFamily | Solute carriers | SLCO1B3 SLC22A20P SLCO1B1 SLC6A6 SLC6A13 SLC25A36 SLC46A3 SLC16A1 SLCO2A1 SLC22A4 SLC14A2 | 4.15e-04 | 395 | 148 | 11 | 752 |
| GeneFamily | Glutamate ionotropic receptor NMDA type subunits | 1.36e-03 | 7 | 148 | 2 | 1201 | |
| GeneFamily | Cation channels sperm associated | 1.36e-03 | 7 | 148 | 2 | 186 | |
| GeneFamily | Transient receptor potential cation channels | 1.52e-03 | 28 | 148 | 3 | 249 | |
| GeneFamily | Acyl-CoA dehydrogenase family | 3.49e-03 | 11 | 148 | 2 | 974 | |
| GeneFamily | Speedy/RINGO cell cycle regulator family | 4.16e-03 | 12 | 148 | 2 | 756 | |
| GeneFamily | Laminin subunits | 4.16e-03 | 12 | 148 | 2 | 626 | |
| GeneFamily | Protein phosphatase catalytic subunits|EF-hand domain containing | 4.89e-03 | 13 | 148 | 2 | 693 | |
| GeneFamily | Anaphase promoting complex |Tetratricopeptide repeat domain containing | 5.68e-03 | 14 | 148 | 2 | 402 | |
| GeneFamily | PHD finger proteins | 6.39e-03 | 90 | 148 | 4 | 88 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 6.52e-03 | 15 | 148 | 2 | 529 | |
| Coexpression | ZENG_GU_ICB_CONTROL_METAGENE_14_PRECICTIVE_ICB_RESPONSE | EPHB2 PCSK5 GBP7 GBP1 GBP2 GBP3 GBP4 BBOX1 FGD3 ADAMTS12 LARGE1 | 7.59e-07 | 198 | 214 | 11 | MM17083 |
| Coexpression | GSE34156_UNTREATED_VS_6H_NOD2_LIGAND_TREATED_MONOCYTE_DN | 2.09e-06 | 177 | 214 | 10 | M8666 | |
| Coexpression | HOWARD_B_CELL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_1DY_UP | 4.06e-06 | 14 | 214 | 4 | M41166 | |
| Coexpression | GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY5_DN | 5.95e-06 | 199 | 214 | 10 | M4635 | |
| Coexpression | GSE17721_CTRL_VS_POLYIC_1H_BMDC_DN | ASH1L CDKAL1 RECQL5 LAMA3 ANXA8 YIPF7 GTF2E2 DCTN4 ASPRV1 CATSPERG | 5.95e-06 | 199 | 214 | 10 | M3709 |
| Coexpression | GSE9037_CTRL_VS_LPS_4H_STIM_BMDM_UP | MYO5A RPLP2 CNP ANAPC4 YWHAH FMNL3 SLC6A6 IGF2R SMARCB1 PRRC1 | 6.22e-06 | 200 | 214 | 10 | M5803 |
| Coexpression | ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP | 1.52e-05 | 176 | 214 | 9 | MM1048 | |
| Coexpression | BLANCO_MELO_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_A594_CELLS_UP | GBP1 GBP2 GBP3 GBP4 GBP5 SP140L SORCS2 AMPD3 ANPEP AOX1 KIAA1217 | 2.54e-05 | 286 | 214 | 11 | M34008 |
| Coexpression | TABULA_MURIS_SENIS_LIMB_MUSCLE_ENDOTHELIAL_CELL_AGEING | 2.65e-05 | 145 | 214 | 8 | MM3744 | |
| Coexpression | NAKAYA_PBMC_IMUVAC_MALE_AGE_14_27YO_1D_POSTBOOST_VS_0DY_PREIMM_TIV_UP | 2.90e-05 | 44 | 214 | 5 | M40896 | |
| Coexpression | GSE17186_NAIVE_VS_CD21HIGH_TRANSITIONAL_BCELL_CORD_BLOOD_DN | 4.01e-05 | 199 | 214 | 9 | M7190 | |
| Coexpression | GSE22886_TCELL_VS_BCELL_NAIVE_UP | 4.01e-05 | 199 | 214 | 9 | M4425 | |
| Coexpression | KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION | 4.04e-05 | 77 | 214 | 6 | M12971 | |
| Coexpression | GSE1925_CTRL_VS_24H_IFNG_STIM_IFNG_PRIMED_MACROPHAGE_DN | 4.17e-05 | 200 | 214 | 9 | M6299 | |
| Coexpression | GSE360_DC_VS_MAC_B_MALAYI_HIGH_DOSE_UP | 4.17e-05 | 200 | 214 | 9 | M5185 | |
| Coexpression | HARALAMBIEVA_PBMC_M_M_R_II_AGE_11_22YO_VACCINATED_VS_UNVACCINATED_7YR_UP | DCDC1 GBP7 SIDT1 GBP1 GBP2 GBP3 FMNL2 CKB GBP4 GBP5 ACSM5 C5 GRIN3A CNP DNAH12 KIAA1217 SLC22A4 LPIN2 LSS MYO16 SP140 | 5.22e-05 | 973 | 214 | 21 | M41080 |
| Coexpression | SALVADOR_MARTIN_PEDIATRIC_TBD_ANTI_TNF_THERAPY_NONRESPONDER_POST_TREATMENT_UP | 5.61e-05 | 26 | 214 | 4 | M41741 | |
| Coexpression | MARTINEZ_TP53_TARGETS_UP | HBS1L MYO5B GBP1 GBP2 GBP3 ITGAV AP2A1 NDUFAF7 UQCRB BBOX1 MNDA ALOX5AP DNAJB1 HACD3 LAMA2 SERPINA12 DCTN4 | 6.10e-05 | 694 | 214 | 17 | MM1039 |
| Coexpression | SENESE_HDAC3_TARGETS_UP | ASH1L NUP58 FMNL2 CDKAL1 LPIN1 YWHAZ SLC6A6 IGF2R TIMP3 SLC16A1 PCNX4 PAPPA CDC27 NDRG4 | 6.17e-05 | 495 | 214 | 14 | M8451 |
| Coexpression | MATSUMIYA_PBMC_MODIFIED_VACCINIA_ANKARA_VACCINE_AGE_4_6MO_BCG_PRIMED_28DY_UP | 6.17e-05 | 10 | 214 | 3 | M41004 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | EPHB2 HIF1A TRPC1 TOGARAM1 GINS1 ADCY9 ANKS1A APPBP2 RAP1A TTC28 DOCK9 INPP5F THOC2 GTF2E2 IGF2R PPP3R1 PHF3 AKAP10 CDC27 | 8.34e-05 | 856 | 214 | 19 | M4500 |
| Coexpression | CASTELLANO_NRAS_TARGETS_UP | 8.57e-05 | 88 | 214 | 6 | MM1087 | |
| Coexpression | DODD_NASOPHARYNGEAL_CARCINOMA_UP | EPHB2 ERICH1 GBP1 NUP58 NEDD1 ITGAV FMNL2 GINS1 GTF3C3 SENP1 GBP4 FCGR1A GBP5 PAN2 ATL2 MNDA PUS7 HACD3 ADNP2 YWHAG YWHAH SLC25A36 PPP3R1 SLC16A1 CDC27 EDRF1 | 8.82e-05 | 1407 | 214 | 26 | M14427 |
| Coexpression | GSE6259_DEC205_POS_DC_VS_BCELL_DN | 8.88e-05 | 172 | 214 | 8 | M6772 | |
| Coexpression | LAKE_ADULT_KIDNEY_C22_ENDOTHELIAL_CELLS_GLOMERULAR_CAPILLARIES | 1.37e-04 | 137 | 214 | 7 | M39241 | |
| Coexpression | SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_7DY_DN | 1.47e-04 | 33 | 214 | 4 | M41194 | |
| Coexpression | AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN | 1.53e-04 | 237 | 214 | 9 | M8897 | |
| Coexpression | GSE45365_WT_VS_IFNAR_KO_CD11B_DC_MCMV_INFECTION_DN | 1.83e-04 | 191 | 214 | 8 | M9977 | |
| Coexpression | MARTINEZ_RB1_AND_TP53_TARGETS_UP | HBS1L MYO5B GBP1 GBP2 GBP3 ITGAV LPIN1 AP2A1 UQCRB BBOX1 MNDA ALOX5AP DNAJB1 HACD3 SERPINA12 DCTN4 | 1.85e-04 | 689 | 214 | 16 | MM1041 |
| Coexpression | DAZARD_UV_RESPONSE_CLUSTER_G6 | 1.95e-04 | 145 | 214 | 7 | M1810 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C2_ADC_2_CELL | 2.04e-04 | 103 | 214 | 6 | M45742 | |
| Coexpression | GSE1740_MCSF_VS_MCSF_AND_IFNG_DAY2_DERIVED_MACROPHAGE_UP | 2.18e-04 | 196 | 214 | 8 | M6156 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | MYO5A RPLP2 ASH1L GBP2 GBP3 BIRC6 MYSM1 LPIN1 GBP5 SERINC1 FMNL1 ALOX5AP FGD3 RAP1A RAP1B DOCK9 PRPF8 YWHAZ FMNL3 PPP3CC PHF3 ATP6AP2 LPIN2 AKAP10 CNOT1 SP140 | 2.24e-04 | 1492 | 214 | 26 | M40023 |
| Coexpression | GSE42724_NAIVE_BCELL_VS_PLASMABLAST_UP | 2.26e-04 | 197 | 214 | 8 | M9797 | |
| Coexpression | WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_DN | 2.27e-04 | 15 | 214 | 3 | M15662 | |
| Coexpression | GSE3982_MAST_CELL_VS_TH1_DN | 2.34e-04 | 198 | 214 | 8 | M5454 | |
| Coexpression | GSE22282_HYPOXIA_VS_NORMOXIA_MYELOID_DC_DN | 2.42e-04 | 199 | 214 | 8 | M8065 | |
| Coexpression | GSE5542_UNTREATED_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_6H_DN | 2.42e-04 | 199 | 214 | 8 | M6519 | |
| Coexpression | GSE3982_NEUTROPHIL_VS_NKCELL_UP | 2.42e-04 | 199 | 214 | 8 | M5530 | |
| Coexpression | GSE411_WT_VS_SOCS3_KO_MACROPHAGE_IL6_STIM_400MIN_DN | 2.50e-04 | 200 | 214 | 8 | M5984 | |
| Coexpression | GSE27786_CD8_TCELL_VS_NKCELL_DN | 2.50e-04 | 200 | 214 | 8 | M4838 | |
| Coexpression | GSE17721_CTRL_VS_CPG_8H_BMDC_DN | 2.50e-04 | 200 | 214 | 8 | M3768 | |
| Coexpression | GSE17186_NAIVE_VS_CD21LOW_TRANSITIONAL_BCELL_DN | 2.50e-04 | 200 | 214 | 8 | M7197 | |
| Coexpression | GSE17580_UNINFECTED_VS_S_MANSONI_INF_TEFF_UP | 2.50e-04 | 200 | 214 | 8 | M3675 | |
| Coexpression | GSE17721_LPS_VS_POLYIC_16H_BMDC_UP | 2.50e-04 | 200 | 214 | 8 | M3818 | |
| Coexpression | GSE1925_CTRL_VS_IFNG_PRIMED_MACROPHAGE_24H_IFNG_STIM_DN | 2.50e-04 | 200 | 214 | 8 | M6309 | |
| Coexpression | GSE5542_UNTREATED_VS_IFNG_TREATED_EPITHELIAL_CELLS_6H_DN | 2.50e-04 | 200 | 214 | 8 | M6513 | |
| Coexpression | DESCARTES_FETAL_LIVER_MESOTHELIAL_CELLS | TRABD2B MYO5B GRIN3A AOX1 LAMA3 DNAH7 SLC16A1 BRINP2 LRP2 PAPPA | 2.69e-04 | 313 | 214 | 10 | M40228 |
| Coexpression | WOOD_EBV_EBNA1_TARGETS_UP | 2.92e-04 | 110 | 214 | 6 | M1696 | |
| Coexpression | NAKAYA_PBMC_FLUAD_MALE_AGE_14_27YO_1D_POSTBOOST_VS_0D_PREIMM_MF59_ADJUVANTED_1DY_ATIV_UP | 3.14e-04 | 40 | 214 | 4 | M40897 | |
| Coexpression | TRAVAGLINI_LUNG_CAPILLARY_INTERMEDIATE_1_CELL | 3.30e-04 | 158 | 214 | 7 | M41666 | |
| Coexpression | KATSANOU_ELAVL1_TARGETS_DN | 3.30e-04 | 158 | 214 | 7 | MM934 | |
| CoexpressionAtlas | dev gonad_e11.5_F_SupCellPrec_Sry_k-means-cluster#1_top-relative-expression-ranked_500 | 2.44e-05 | 120 | 208 | 8 | gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_k1_500 | |
| CoexpressionAtlas | dev gonad_e11.5_F_SupCellPrec_Sry_top-relative-expression-ranked_1000 | TRABD2B ACADL MYO5B GBP1 GBP2 LHPP FMNL2 CLCN2 ACOT2 TTC38 PUS7 TDRD5 RAP1A TRPC7 ANPEP KBTBD6 DOCK9 DNAH7 GTF2E2 PPP3CC CNOT1 | 3.53e-05 | 791 | 208 | 21 | gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_1000 |
| ToppCell | COVID-19-kidney-PCT-S1/S2|kidney / Disease (COVID-19 only), tissue and cell type | PCSK5 TRABD2B MOGAT1 BBOX1 TTC38 ANPEP AOX1 SLC6A13 SUGCT ASS1 LRP2 | 1.86e-09 | 184 | 217 | 11 | dc71f22583fc54b89b242cbb602f4bbe86f576ec |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | PCSK5 TRABD2B ADCY9 BBOX1 TTC38 ANPEP AOX1 SLC6A13 SUGCT ASS1 LRP2 | 2.08e-09 | 186 | 217 | 11 | 5784d255e9ca449d375d81938d0fbbd8a7eb44f6 |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | PCSK5 TRABD2B ADCY9 BBOX1 TTC38 ANPEP SLC6A13 SUGCT ASS1 LRP2 | 2.97e-08 | 187 | 217 | 10 | 3ae3b8de1a195d4d5057cf3c64fcdb5f48681ce5 |
| ToppCell | COVID-19-kidney-Mito-rich_PCT|kidney / Disease (COVID-19 only), tissue and cell type | TRABD2B MOGAT1 BBOX1 ANPEP AOX1 SLC6A13 SUGCT ASS1 LRP2 PAPPA | 2.97e-08 | 187 | 217 | 10 | 738ec2611b4be6a08eedad16b57fba84e1f11fef |
| ToppCell | B_cells-ISG-high_B_cells|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 4.41e-08 | 195 | 217 | 10 | b64d9e1a8834401b4dc501566546647754ae21fc | |
| ToppCell | NS-critical-LOC|critical / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.10e-08 | 198 | 217 | 10 | ff9b9065f5d91a7aff99121bddc3e86f6b1c8a8d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.27e-07 | 177 | 217 | 9 | 2f81b26be89cc2fd8eafadaf7eae3c6ad6521462 | |
| ToppCell | COVID-19-kidney-PCT-S1/S2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.38e-07 | 178 | 217 | 9 | 23a12d3d971b857d5be8e907334d1f6b49eeeb32 | |
| ToppCell | COVID-19-kidney-PCT-S2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.62e-07 | 180 | 217 | 9 | 358923e4228035a3e90e2957392089219e90dcd7 | |
| ToppCell | COVID-19-kidney-tDL|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.62e-07 | 180 | 217 | 9 | 864c895b5eaedefae86f5829fa344f7b686fb59f | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.87e-07 | 182 | 217 | 9 | e1e58176f533092b6b974ca1ce8b02192a6e193d | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.87e-07 | 182 | 217 | 9 | 4a9c13932e7163fd37a3dcc4c6ca3bbea5372459 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.87e-07 | 182 | 217 | 9 | 57bb5a2da976464ba7c4460106bd9f692008ebd9 | |
| ToppCell | COVID-19-kidney-Mito-rich_PCT|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.30e-07 | 185 | 217 | 9 | 1bbc2ba8a20f72f61981b1301cdd6018cdd9150d | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Macrophage-macrophage,_alveolar-Macro_c2-CCL3L1|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.30e-07 | 185 | 217 | 9 | f30fb9d75cdb757b206312992aaf7485bc900f96 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.45e-07 | 186 | 217 | 9 | 8287146f0ba415ea04475588117d4668ae00f75c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.45e-07 | 186 | 217 | 9 | b1edc341d6684b347dc9e21b34f62f51d095d735 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.61e-07 | 187 | 217 | 9 | 1b82920588f9e26ef1db244d452736d75fcfd342 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.61e-07 | 187 | 217 | 9 | 71eb26ebf60cb0848e5bf1cd01edccda621aecd8 | |
| ToppCell | COVID-19-kidney-tDL|kidney / Disease (COVID-19 only), tissue and cell type | 3.61e-07 | 187 | 217 | 9 | d35d27ca3c0e65f92f4508e1cb98a743f44fdcdf | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.61e-07 | 187 | 217 | 9 | dcf6475ece5b34d9d58a0d1f51c18acedb19c119 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.61e-07 | 187 | 217 | 9 | f1356273bd3587b6883295edf15cb9cdb706c057 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.61e-07 | 187 | 217 | 9 | c1e4c0345f9bfa0538730bad5ff3fa5240168b25 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Alv_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | TSPAN12 GBP7 SLCO1B3 GBP3 DOCK9 FMNL3 TIMP3 SLCO2A1 KIAA1217 | 4.31e-07 | 191 | 217 | 9 | a7b18bcf27c38ad2353c239ecb309c80f3ef3359 |
| ToppCell | Leuk-UTI|World / Disease, Lineage and Cell Type | 4.71e-07 | 193 | 217 | 9 | 26119a0b5d7684022fd16b8b73a0ef5a7d70f3d1 | |
| ToppCell | BL|World / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.59e-07 | 197 | 217 | 9 | 1acf0191fa0a25cd20bfd9ea7bf727a1555986a1 | |
| ToppCell | NS-critical-LOC-Myeloid|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.83e-07 | 198 | 217 | 9 | 58f2bc88d92550fb0b7c2e46c63c49ec6777001c | |
| ToppCell | Control-Control-Lymphocyte-T/NK-CD4+_T_activated|Control / Disease, condition lineage and cell class | 5.83e-07 | 198 | 217 | 9 | ee71543559836fd59adc0da877b2ca538cba60cb | |
| ToppCell | Severe_COVID-19-Myeloid-MoAM2|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 6.08e-07 | 199 | 217 | 9 | 2f9f75c2c7e00a855ce11411ff7b8271c9eec45f | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.08e-07 | 199 | 217 | 9 | 37e3c00b127be4985843d8758c0ae0384f3bccfe | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.08e-07 | 199 | 217 | 9 | 97888e2ae11178d1d526be1d7c518c51cffe976b | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM2|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.08e-07 | 199 | 217 | 9 | e22767758459deabefee2ea9d2b9b279cacfd015 | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.08e-07 | 199 | 217 | 9 | 64bb1258e7ba56afd937c5ae47226fff7a1ccadb | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.77e-06 | 168 | 217 | 8 | fa0d251693935116adf633d02b7ec4a295100865 | |
| ToppCell | Endothelial-Endothelial-F|Endothelial / shred on cell class and cell subclass (v4) | 2.31e-06 | 122 | 217 | 7 | 2cb8bb63c69aed4d4504b9d97219b8707666f950 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.83e-06 | 179 | 217 | 8 | 78fae47ec9bff4e0159a86a281e831d7f8ee925a | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Calb2_Necab1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.86e-06 | 126 | 217 | 7 | a4fc7ac4931d2fc8aa8196a62d809b698937aa9c | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.95e-06 | 180 | 217 | 8 | 1363b3254470f6ff98630d1df83a1bdbacc137e0 | |
| ToppCell | IPF-Epithelial-ATI|World / Disease state, Lineage and Cell class | 3.34e-06 | 183 | 217 | 8 | 31fef35ecf30162662f24d335d8f0cceacc07039 | |
| ToppCell | COVID-19-kidney-PCT-S1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.34e-06 | 183 | 217 | 8 | 6878d14026c3df6aa12e45dfad94b32fa9d9b0b7 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.34e-06 | 183 | 217 | 8 | 04d3cc76038b8192c915f1c08c3e26f2ad3b3779 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.34e-06 | 183 | 217 | 8 | 85446581999cd66b171c4f69b7eb8b0bbbaa8617 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.47e-06 | 184 | 217 | 8 | 9434731f651820b05335085582960f08fbf895de | |
| ToppCell | critical-Myeloid-Monocyte-derived_Macrophage|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.92e-06 | 187 | 217 | 8 | 72e4aec49ea0c5fe6cee2a1a46369dbc90cd3fad | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.0.1.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.92e-06 | 187 | 217 | 8 | cbe25fb3fc8ed6245dc767c884c298c89a774cce | |
| ToppCell | T_cells-ISG-high_CD4+_T_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 4.07e-06 | 188 | 217 | 8 | 6f8946d4710f6e32c937213f99b790b098b8819c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.24e-06 | 189 | 217 | 8 | 204ab61ae606b2d9be0cb6bf6a83a011740693a8 | |
| ToppCell | COVID-19-kidney-PCT-S2|kidney / Disease (COVID-19 only), tissue and cell type | 4.24e-06 | 189 | 217 | 8 | 0be5c669b6b308bd98ddb70c84877c62a6244bbd | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.40e-06 | 190 | 217 | 8 | 305fbef734c350cfbf786ca7ff6e07093aab56ea | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.58e-06 | 191 | 217 | 8 | 1c1d13144259b998d4a0e85142f7afef2ef1e63f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.58e-06 | 191 | 217 | 8 | 3c464645d0e7e423f791bd63bf5bcf11f6b590d3 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_aerocyte_capillary-EC_aerocyte_capillary_L.2.0.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.94e-06 | 193 | 217 | 8 | aaf681f16f310168e4719464814a1fc0a2f8431a | |
| ToppCell | LAM-Myeloid-Macrophage|LAM / Condition, Lineage and Cell class | 5.33e-06 | 195 | 217 | 8 | 85abe51e47b567e6edcadfbe8cf02c2f2f0bb133 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_CCL3+|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.33e-06 | 195 | 217 | 8 | c264b052bc50c5bd92816e12fbbe08014d2002f4 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_CCL3+-Alveolar_macrophage_CCL3+_L.1.0.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.33e-06 | 195 | 217 | 8 | f5351932634d5913688b15f16da76198c91e9b53 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.33e-06 | 195 | 217 | 8 | 1e28617ca55e5f318a228357737b968dfac8cca0 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.33e-06 | 195 | 217 | 8 | ec218ae03ebf8588996e86d6d9a8ea3cf71affaa | |
| ToppCell | Endothelial-F|World / shred on cell class and cell subclass (v4) | 5.49e-06 | 139 | 217 | 7 | 32d3c5d35e6c4205711c3500d736fd108443e6b4 | |
| ToppCell | primary_visual_cortex-Neuronal|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.53e-06 | 196 | 217 | 8 | 8efc2b3a95f57c31be203ac781b2098d4909297f | |
| ToppCell | severe-Myeloid-Neutrophils_2|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 5.75e-06 | 197 | 217 | 8 | c8a90d82170cf20e14aebecddcf7cc0ca56cda87 | |
| ToppCell | BAL-Severe-cDC_1|Severe / Compartment, Disease Groups and Clusters | 6.19e-06 | 199 | 217 | 8 | 9f5750212b887f92761ade33fc6e108cd5275297 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_other-Macro_interstitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.19e-06 | 199 | 217 | 8 | 841338719d042247966867ac608146395eb8c4d9 | |
| ToppCell | severe|World / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 6.19e-06 | 199 | 217 | 8 | c24aacef7405700bc5d0b736a38feea12b7f17c8 | |
| ToppCell | facs-Tongue-nan-3m-Epithelial-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.19e-06 | 199 | 217 | 8 | 8d50e1ee58710d896c0204937331d9f4dcd38de0 | |
| ToppCell | medial-Endothelial-Capillary_Intermediate_1-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.42e-06 | 200 | 217 | 8 | 707148e01e961097819a05437a842b7d3bf72b0a | |
| ToppCell | medial-2-Endothelial-Capillary_Intermediate_1|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.42e-06 | 200 | 217 | 8 | a8adf5902540f6bb15b72efbb9c389b59d67e001 | |
| ToppCell | medial-Endothelial-Capillary_Intermediate_1|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.42e-06 | 200 | 217 | 8 | 3ef7b7728615710c691aed8977e2582f19692cf9 | |
| ToppCell | Sepsis-Leuk-UTI|Sepsis / Disease, condition lineage and cell class | 6.42e-06 | 200 | 217 | 8 | 7d92b24c0c888dd46e40b7e3c6c2645c3604f132 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic-Neutrophil-Neu_c1-IL1B|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.32e-05 | 159 | 217 | 7 | fb9a45c1d596226128ce4f1adaebb066766e590a | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial-Hepatocyte_(Pericentral)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-05 | 160 | 217 | 7 | c42bcc6c7d113f0db43febb088b75ca4ac7cb7a3 | |
| ToppCell | droplet-Spleen-SPLEEN-1m-Myeloid-granulocyte|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.68e-05 | 165 | 217 | 7 | b671c6a950e70f64776c2104baccb3dc2bb6a1ba | |
| ToppCell | facs-Kidney-nan-3m-Epithelial-epithelial_cell_of_proximal_tubule|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.96e-05 | 169 | 217 | 7 | ee27bcfe3f9a295ec5fb0a375d77d1050e5cbaad | |
| ToppCell | facs-Kidney-nan-3m-Epithelial-epithelial_cell_of_proximal_tubule|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.96e-05 | 169 | 217 | 7 | 922086f218135b734b7d370b871923e50141edce | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.11e-05 | 171 | 217 | 7 | f5014e3c387fe3118944af392abe10d6b9b0abab | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.28e-05 | 173 | 217 | 7 | 8888434641ea554a9b62c436e87920378eef29cd | |
| ToppCell | Striatum-Macroglia-CSF_related-EPENDYMAL-Ependyma_Ccdc153.Ccdc153_(Ccdc153)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.35e-05 | 117 | 217 | 6 | 26dec09112532f351fb7a2202bae84c365707b40 | |
| ToppCell | Striatum-Macroglia-CSF_related-EPENDYMAL-Ependyma_Ccdc153.Ccdc153_(Ccdc153)|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.35e-05 | 117 | 217 | 6 | db053c874e6739052dff1f91643e51b306236237 | |
| ToppCell | Striatum-Macroglia-CSF_related-EPENDYMAL-Ependyma_Ccdc153.Ccdc153_(Ccdc153)--|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.35e-05 | 117 | 217 | 6 | 80780223502d18f0d86a29ff3cb74aa8235103c7 | |
| ToppCell | Striatum-Macroglia-CSF_related-EPENDYMAL|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.35e-05 | 117 | 217 | 6 | 40889f4a387846abbf54469cc4faf616bfe348d0 | |
| ToppCell | Striatum-Macroglia-CSF_related|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.35e-05 | 117 | 217 | 6 | e12e37e393257db85f7f5c13454095c44f59d374 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.5.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.36e-05 | 174 | 217 | 7 | d5c22b43531414951666ee7542a66ed9380e2d14 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.54e-05 | 176 | 217 | 7 | 1595dbeee336a81e581325d63208ec6262664ee9 | |
| ToppCell | COPD-Epithelial-Aberrant_Basaloid|COPD / Disease state, Lineage and Cell class | 2.54e-05 | 176 | 217 | 7 | 11d867bcb4f2471b4e13a5f7dc1c24286197f26d | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.74e-05 | 178 | 217 | 7 | 0b398656f26c4061b11ccf98908d0e2e1367585a | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.84e-05 | 179 | 217 | 7 | d1ef7e1cb00336118e387b47f4f8120f53584391 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.94e-05 | 180 | 217 | 7 | f8bdfd7bf7b3d52c659a29d8f5f80858e79da83e | |
| ToppCell | 367C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.94e-05 | 180 | 217 | 7 | 162cec1734e560c068cd61717e40e18dcf92308c | |
| ToppCell | AT1-AT2_cells-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 2.94e-05 | 180 | 217 | 7 | 3c7b2033821f9e34e2924bd8655f566edcbcc7d3 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.94e-05 | 180 | 217 | 7 | 33c86c22ba877358cd8c1e39b5c0b3dc3a45b7dd | |
| ToppCell | Thalamus-Macroglia-CSF_related-EPENDYMAL-Ependymal.Ccdc153_(Ccdc153)-|Thalamus / BrainAtlas - Mouse McCarroll V32 | 2.98e-05 | 122 | 217 | 6 | aca079f2f033cc1ac13c4ee02d490b6a514cbd5c | |
| ToppCell | Thalamus-Macroglia-CSF_related-EPENDYMAL-Ependymal.Ccdc153_(Ccdc153)--|Thalamus / BrainAtlas - Mouse McCarroll V32 | 2.98e-05 | 122 | 217 | 6 | ac38130010f76648757eac700a8039f3960ddde3 | |
| ToppCell | Thalamus-Macroglia-CSF_related-EPENDYMAL|Thalamus / BrainAtlas - Mouse McCarroll V32 | 2.98e-05 | 122 | 217 | 6 | 7ab0b63244116e74c5783c3293cf08224d094d0a | |
| ToppCell | Thalamus-Macroglia-CSF_related|Thalamus / BrainAtlas - Mouse McCarroll V32 | 2.98e-05 | 122 | 217 | 6 | eb944243424460bf5c66aced3ed7b7a1b6486ac7 | |
| ToppCell | Thalamus-Macroglia-CSF_related-EPENDYMAL-Ependymal.Ccdc153_(Ccdc153)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 2.98e-05 | 122 | 217 | 6 | 9b0d6b0a394560ff5aadcd3b21519c2393e6def8 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.04e-05 | 181 | 217 | 7 | bd7e9437839bca543ca5945df43d6525e6a312a8 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.04e-05 | 181 | 217 | 7 | 9542c19edc9bd2cba68c01c2a8407705398e3011 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.04e-05 | 181 | 217 | 7 | 8f04f8cac5d705dc5f6cf6f4516d6e45b0aa4ae5 | |
| ToppCell | NS-moderate-d_07-13-Myeloid-Monocyte-derived_Macrophage|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.15e-05 | 182 | 217 | 7 | e03e995e5fd14fc6a7559b83c0ca4e7ccc8e3d0f | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.15e-05 | 182 | 217 | 7 | 84f4322ec3d12cb217009f9215af01ebfabc82b4 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.5.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.26e-05 | 183 | 217 | 7 | 103c4c4595d8daa677679fd2fa1e99cd398e56dd | |
| Drug | Acetylsalicylsalicylic acid [530-75-6]; Down 200; 13.4uM; MCF7; HT_HG-U133A | EPHB2 NDRG3 CLCN2 ATL2 TTC38 LAMA3 PPP3R1 PPP5C TMPRSS2 LSS WDTC1 | 2.20e-06 | 195 | 211 | 11 | 2223_DN |
| Drug | Dronabinol | TRPC1 CKB SERINC1 CNP ANAPC4 SPIC DNAJB1 SGTB ANPEP POLE ANXA8 GRIK1 DNAH7 YWHAG YWHAZ SLC6A6 SLC25A36 PPP3R1 SLC16A1 MAST1 DCTN4 CTSD NDRG4 PRRC1 | 3.87e-06 | 905 | 211 | 24 | ctd:D013759 |
| Drug | nitrosobenzylmethylamine | HIF1A MYO5B PDK2 PSMB7 GBP2 LHPP CKB ACOT2 ALOX5 RAP1B AOX1 YWHAG YWHAH YWHAZ SERPINA12 SLC16A1 LRP2 CTSD | 5.35e-06 | 561 | 211 | 18 | ctd:C014707 |
| Drug | Chlorthalidone [77-36-1]; Down 200; 11.8uM; PC3; HT_HG-U133A | PDK2 TRPC1 ASH1L CDKAL1 PWP2 EGLN2 PPP3CC PPP3R1 NDRG4 WDTC1 | 1.48e-05 | 195 | 211 | 10 | 7152_DN |
| Drug | chlorpromazine hydrochloride; Down 200; 1uM; MCF7; HT_HG-U133A | 1.54e-05 | 196 | 211 | 10 | 5577_DN | |
| Drug | Triprolidine hydrochloride [550-70-9]; Up 200; 12.8uM; MCF7; HT_HG-U133A | NDOR1 ASH1L NF2 ATL2 LAMA3 SLC6A6 GLCE SLC22A4 BRINP2 TMPRSS2 | 1.69e-05 | 198 | 211 | 10 | 7008_UP |
| Drug | Cyclopenthiazide [742-20-1]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 1.69e-05 | 198 | 211 | 10 | 7325_DN | |
| Drug | Molindone hydrochloride [15622-65-8]; Down 200; 12.8uM; MCF7; HT_HG-U133A | LHPP NDRG3 AOX1 SLC6A6 PPP3CC SLC16A1 GPR153 LSS EDRF1 LARGE1 | 1.76e-05 | 199 | 211 | 10 | 7337_DN |
| Drug | fluphenazine dihydrochloride; Down 200; 10uM; MCF7; HT_HG-U133A | 1.84e-05 | 200 | 211 | 10 | 6996_DN | |
| Disease | myoglobinuria (implicated_via_orthology) | 3.50e-07 | 3 | 209 | 3 | DOID:0080108 (implicated_via_orthology) | |
| Disease | severe acute respiratory syndrome, COVID-19 | EPHB2 EIF3L SORCS2 TRPM1 ANAPC4 TRPC7 SGTB HACD3 HELQ ADAMTS12 PPP5C KIAA1217 CHSY3 | 2.02e-05 | 447 | 209 | 13 | EFO_0000694, MONDO_0100096 |
| Disease | Bipolar Disorder | HIF1A SORCS2 GRIN3A DNAJB1 TRPC7 DOCK9 GRIK1 YWHAH YWHAZ SLC6A13 PPP3CC TPH2 AKAP10 | 3.96e-05 | 477 | 209 | 13 | C0005586 |
| Disease | HYPERBILIRUBINEMIA, ROTOR TYPE, DIGENIC | 4.99e-05 | 2 | 209 | 2 | C4016905 | |
| Disease | Rotor Syndrome | 4.99e-05 | 2 | 209 | 2 | C0220991 | |
| Disease | Rotor syndrome | 4.99e-05 | 2 | 209 | 2 | cv:C0220991 | |
| Disease | HYPERBILIRUBINEMIA, ROTOR TYPE | 4.99e-05 | 2 | 209 | 2 | 237450 | |
| Disease | SCHWANNOMATOSIS 1 | 1.49e-04 | 3 | 209 | 2 | C4048809 | |
| Disease | hereditary spastic paraplegia 3A (implicated_via_orthology) | 1.49e-04 | 3 | 209 | 2 | DOID:0110791 (implicated_via_orthology) | |
| Disease | non-Hodgkin lymphoma (is_marker_for) | 1.49e-04 | 3 | 209 | 2 | DOID:0060060 (is_marker_for) | |
| Disease | neurofibromatosis 2 (is_implicated_in) | 1.49e-04 | 3 | 209 | 2 | DOID:0111252 (is_implicated_in) | |
| Disease | lipid metabolism disorder (implicated_via_orthology) | 1.50e-04 | 15 | 209 | 3 | DOID:3146 (implicated_via_orthology) | |
| Disease | Moyamoya disease | 1.83e-04 | 40 | 209 | 4 | MONDO_0016820 | |
| Disease | Schizophrenia | MYO5B CKB TRPM1 GRIN3A CNP ADNP2 LAMA2 GRIK1 GRIN2C LMOD2 ADAMTS12 PPP3CC PPP3R1 GPR153 TPH2 LRP2 MYO16 | 2.00e-04 | 883 | 209 | 17 | C0036341 |
| Disease | Kabuki make-up syndrome | 2.97e-04 | 4 | 209 | 2 | C0796004 | |
| Disease | Schwannomatosis | 2.97e-04 | 4 | 209 | 2 | C1335929 | |
| Disease | Neurofibromatosis, Type 3, mixed central and peripheral | 2.97e-04 | 4 | 209 | 2 | C2931480 | |
| Disease | bilirubin metabolic disorder (implicated_via_orthology) | 4.92e-04 | 5 | 209 | 2 | DOID:2741 (implicated_via_orthology) | |
| Disease | Neurofibromatosis 3 | 4.92e-04 | 5 | 209 | 2 | C0917817 | |
| Disease | reticulocyte count | HBS1L NDOR1 ASH1L PSMB7 BIRC6 SENP1 PLCB3 ALOX5 AMPD3 LAMA3 COPS3 PRPF8 SLCO1B1 YWHAZ SLC22A4 MAST1 AKAP10 ASPRV1 | 4.93e-04 | 1045 | 209 | 18 | EFO_0007986 |
| Disease | deoxycarnitine measurement | 7.35e-04 | 6 | 209 | 2 | EFO_0800259 | |
| Disease | tetradecadienedioate (C14:2-DC) measurement | 7.35e-04 | 6 | 209 | 2 | EFO_0800585 | |
| Disease | bilirubin metabolic disorder (is_implicated_in) | 7.35e-04 | 6 | 209 | 2 | DOID:2741 (is_implicated_in) | |
| Disease | meningioma (is_implicated_in) | 7.35e-04 | 6 | 209 | 2 | DOID:3565 (is_implicated_in) | |
| Disease | obesity (implicated_via_orthology) | 8.93e-04 | 215 | 209 | 7 | DOID:9970 (implicated_via_orthology) | |
| Disease | octadecanedioylcarnitine (C18-DC) measurement | 1.02e-03 | 7 | 209 | 2 | EFO_0800371 | |
| Disease | X-16935 measurement | 1.02e-03 | 7 | 209 | 2 | EFO_0800763 | |
| Disease | X-24747 measurement | 1.36e-03 | 8 | 209 | 2 | EFO_0022135 | |
| Disease | deoxycholic acid glucuronide measurement | 1.36e-03 | 8 | 209 | 2 | EFO_0800575 | |
| Disease | reticulocyte measurement | HBS1L NDOR1 ASH1L PSMB7 BIRC6 CDKAL1 SENP1 PLCB3 ALOX5 SPIC AMPD3 PRPF8 SLCO1B1 MACO1 LPIN2 MAST1 ASPRV1 | 1.42e-03 | 1053 | 209 | 17 | EFO_0010700 |
| Disease | urate measurement, bone density | TM9SF3 GBP3 CATSPER3 CDKAL1 GBP4 GBP5 TTC28 GRIN2C ASS1 TPH2 SEL1L2 MYO16 | 1.64e-03 | 619 | 209 | 12 | EFO_0003923, EFO_0004531 |
| Disease | Erythrocytosis familial, 1 | 1.74e-03 | 9 | 209 | 2 | C4551637 | |
| Disease | X-11381 measurement | 1.74e-03 | 9 | 209 | 2 | EFO_0021228 | |
| Disease | hexadecenedioate (C16:1-DC) measurement | 1.74e-03 | 9 | 209 | 2 | EFO_0800562 | |
| Disease | X-17653 measurement | 1.74e-03 | 9 | 209 | 2 | EFO_0800783 | |
| Disease | X-21467 measurement | 1.74e-03 | 9 | 209 | 2 | EFO_0020007 | |
| Disease | response to serotonin-norephinephrine reuptake inhibitor | 2.11e-03 | 36 | 209 | 3 | EFO_0006325 | |
| Disease | acylcarnitine measurement | 2.15e-03 | 127 | 209 | 5 | EFO_0005059 | |
| Disease | morbid obesity (is_marker_for) | 2.16e-03 | 10 | 209 | 2 | DOID:11981 (is_marker_for) | |
| Disease | octadecanedioate measurement | 2.16e-03 | 10 | 209 | 2 | EFO_0021056 | |
| Disease | Lung diseases | 2.32e-03 | 78 | 209 | 4 | C0024115 | |
| Disease | refractive error, age at onset, Myopia | 2.61e-03 | 193 | 209 | 6 | EFO_0004847, HP_0000545, MONDO_0004892 | |
| Disease | response to statin, myopathy | 2.63e-03 | 11 | 209 | 2 | EFO_0004145, GO_0036273 | |
| Disease | X-11308 measurement | 2.63e-03 | 11 | 209 | 2 | EFO_0800693 | |
| Disease | gastrointestinal stromal tumor (is_implicated_in) | 2.63e-03 | 11 | 209 | 2 | DOID:9253 (is_implicated_in) | |
| Disease | heat shock protein beta-1 measurement | 3.14e-03 | 12 | 209 | 2 | EFO_0010595 | |
| Disease | nicotine dependence (implicated_via_orthology) | 3.14e-03 | 12 | 209 | 2 | DOID:0050742 (implicated_via_orthology) | |
| Disease | arachidonoylcarnitine (C20:4) measurement | 3.14e-03 | 12 | 209 | 2 | EFO_0800544 | |
| Disease | Congenital muscular dystrophy | 3.14e-03 | 12 | 209 | 2 | cv:C0699743 | |
| Disease | HbA1c measurement | HBS1L NDOR1 ASH1L ADCY9 CDKAL1 SENP1 PLCB3 AMPD3 HACD3 LMOD2 MACO1 MAST1 | 3.31e-03 | 675 | 209 | 12 | EFO_0004541 |
| Disease | amino acid measurement | EPHB2 DCDC1 ACAD11 C5 DNAH7 SLC6A13 GTF2E2 DNAH12 BRINP2 LRP2 TMPRSS2 MYO16 | 3.43e-03 | 678 | 209 | 12 | EFO_0005134 |
| Disease | Malignant neoplasm of liver | 3.48e-03 | 142 | 209 | 5 | C0345904 | |
| Disease | Liver neoplasms | 3.48e-03 | 142 | 209 | 5 | C0023903 | |
| Disease | dihomo-linolenoylcarnitine (C20:3n3 or 6) measurement | 3.70e-03 | 13 | 209 | 2 | EFO_0800547 | |
| Disease | glycochenodeoxycholate glucuronide (1) measurement | 3.70e-03 | 13 | 209 | 2 | EFO_0800474 | |
| Disease | imidazole lactate measurement | 3.70e-03 | 13 | 209 | 2 | EFO_0800004 | |
| Disease | X-24588 measurement | 3.70e-03 | 13 | 209 | 2 | EFO_0800898 | |
| Disease | colon carcinoma (is_marker_for) | 3.70e-03 | 13 | 209 | 2 | DOID:1520 (is_marker_for) | |
| Disease | common cold (is_marker_for) | 3.70e-03 | 13 | 209 | 2 | DOID:10459 (is_marker_for) | |
| Disease | Paranoid Schizophrenia | 3.70e-03 | 13 | 209 | 2 | C0036349 | |
| Disease | cup-to-disc ratio measurement | 3.73e-03 | 430 | 209 | 9 | EFO_0006939 | |
| Disease | hemorrhoid | 4.03e-03 | 147 | 209 | 5 | EFO_0009552 | |
| Disease | Disorder of eye | 4.13e-03 | 212 | 209 | 6 | C0015397 | |
| Disease | neuronal ceroid lipofuscinosis (implicated_via_orthology) | 4.30e-03 | 14 | 209 | 2 | DOID:14503 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of prostate | EPHB2 HIF1A ASH1L CHD6 ALOX5 AOX1 IGF2R LRP2 TMPRSS2 CDC27 CTSD | 4.69e-03 | 616 | 209 | 11 | C0376358 |
| Disease | urate measurement | SPNS1 DCDC1 ASH1L BIRC6 CDKAL1 PLCB3 ANAPC4 POLE GRIK1 SLCO1B1 TIGD2 LRP2 SLC14A2 LARGE1 | 4.87e-03 | 895 | 209 | 14 | EFO_0004531 |
| Disease | X-17654 measurement | 4.93e-03 | 15 | 209 | 2 | EFO_0800784 | |
| Disease | osteoarthritis, knee | 5.46e-03 | 158 | 209 | 5 | EFO_0004616 | |
| Disease | phosphatidylcholine 38:3 measurement | 5.61e-03 | 16 | 209 | 2 | EFO_0010385 | |
| Disease | hepatocellular carcinoma (is_marker_for) | 5.84e-03 | 301 | 209 | 7 | DOID:684 (is_marker_for) | |
| Disease | thyroxine measurement, triiodothyronine measurement | 6.33e-03 | 17 | 209 | 2 | EFO_0005130, EFO_0008392 | |
| Disease | partial epilepsy | 6.33e-03 | 17 | 209 | 2 | EFO_0004263 | |
| Disease | bone density | 6.69e-03 | 388 | 209 | 8 | EFO_0003923 | |
| Disease | metabolite measurement | ACADL CDKAL1 LACTB ACOT2 BBOX1 TTC38 SLCO1B1 IGF2R SUGCT SLC22A4 | 6.89e-03 | 560 | 209 | 10 | EFO_0004725 |
| Disease | ecosanoids measurement | 7.01e-03 | 55 | 209 | 3 | EFO_0020044 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GLYAYGAIMAGLIQK | 216 | Q9HAC7 | |
| AFAKRFGRSFQYMQY | 156 | Q8NAT2 | |
| MKGDYYRYLAEVATG | 126 | P61981 | |
| AGLMYLFVRQKYFVG | 86 | P20292 | |
| YDLERKGGYLMLSFI | 621 | Q6ZRH7 | |
| LNFLKSTQEMYFYDG | 341 | Q86X53 | |
| LLDFRAKMQGVYGHY | 216 | Q6ZTR7 | |
| AKMQGVYGHYDTRLL | 221 | Q6ZTR7 | |
| VNGVYRIGLYALKDM | 2236 | Q9NR48 | |
| KIYYDGMGQDLADIR | 351 | Q9P2K9 | |
| RYAMGAKSVGPLQYA | 46 | Q96NT0 | |
| ELYAYGMFKIARVTG | 186 | Q9UJX5 | |
| SGGYLVLYKMNYATR | 821 | Q9NR09 | |
| GKQFTYLYIADGMQS | 136 | Q86XQ3 | |
| YYGGMIYTGLKNFER | 186 | Q9UNS2 | |
| SALLGEENKGFYYIM | 271 | P28330 | |
| MKGDYYRYLAEVASG | 126 | Q04917 | |
| SLYQRTYAGKMTFGR | 576 | O43572 | |
| DLELYRYSGVNMTGF | 266 | P39086 | |
| QNLGRMYLFYGNKTS | 771 | O95782 | |
| AGKGFAVMALAYYNY | 241 | P49753 | |
| YITGDRARMDKDGYF | 451 | Q6NUN0 | |
| GFMYSLIGLYDLKET | 511 | O94923 | |
| HYGNLGRLYQSMRKF | 431 | Q92624 | |
| AGFYRSEYMEGNVRK | 191 | P15144 | |
| FAERLYYAMKGAGTD | 421 | P20073 | |
| GYEANYLGSMLIKDL | 941 | Q92625 | |
| FRIYDMDKDGYISNG | 96 | P63098 | |
| DLFAVGYGSYDFMKQ | 346 | Q9UI46 | |
| MGKDYYQTLGLARGA | 1 | P25685 | |
| YNRFKGRNDLMEYAK | 151 | P00966 | |
| GFLSNSYIMEKRYGN | 111 | P58397 | |
| LSYFKMAGIAQGVYS | 311 | Q709F0 | |
| YLINSYFGLRTEEMG | 181 | Q6IQ32 | |
| LKTENYLGGEYFARM | 406 | Q01432 | |
| YLGKYKAGFMNDGRI | 851 | Q06278 | |
| YMKNGQGFALVYSIT | 71 | P62834 | |
| YMKNGQGFALVYSIT | 71 | P61224 | |
| YYNAAGFNKLGLMRD | 21 | P14927 | |
| LKQMLFRYQGYIGAA | 126 | Q99436 | |
| YKDFKELGRFMLRYG | 656 | Q9Y450 | |
| RLYYAMKGAGTRDGT | 261 | P13928 | |
| GVFQYNFGLMTYRKA | 266 | Q96PD6 | |
| YLFIGMGINYRLLAK | 436 | P53985 | |
| KLTEAFKYFLQGMGY | 301 | Q9UGV2 | |
| NLKYMARGGLIIFDY | 136 | Q504Q3 | |
| SGAKMYIQGVLLALY | 381 | M0R2J8 | |
| NGYKFLYCSARAIGM | 681 | Q9BQK8 | |
| GEFFLLGLMAYDRYV | 111 | Q6IF00 | |
| QDMSRRYGFAALKYL | 736 | O95461 | |
| VMYLGNKDASRDYIG | 2436 | Q16787 | |
| GSSRGKIYQYDLRML | 266 | Q8NHV4 | |
| RKGYLFMYNLVQFLG | 146 | Q9P035 | |
| KAYYAGHVLGAAMFQ | 151 | Q5TA45 | |
| DGDLAGRYYALKSMT | 166 | P12277 | |
| FYLLMDGLSAEEKYG | 596 | Q9Y6X6 | |
| VAGEYGRHSLYKMLG | 256 | Q9Y262 | |
| GRHSLYKMLGYFSLV | 261 | Q9Y262 | |
| DAAMSLQKYGRALRY | 701 | Q3B7T1 | |
| TTGQYRMLAKRGGYV | 301 | Q16665 | |
| GRAMYQRAKELYASA | 401 | Q9NR71 | |
| DLLKFGNAMLYGYQV | 406 | P83111 | |
| GNAMLYGYQVGLFKN | 411 | P83111 | |
| IYLVMYGARGNKNSG | 316 | Q8IVV2 | |
| MSTFGYRRGLSKYES | 1 | Q6P5Q4 | |
| LGFGFKSYVSYKMRL | 166 | Q8N5G2 | |
| RTVAGYGRYSGKMYF | 511 | P29323 | |
| ILKDYYTAALSGGLM | 66 | Q63HM2 | |
| MGQDGTVYRKFKYGL | 1826 | Q92824 | |
| IVEMKKGSNGYGFYL | 121 | A8MUH7 | |
| YGYGGDFVALDRMAK | 346 | Q6NV75 | |
| QKYYRQMRKGGFSFS | 431 | P48449 | |
| NILMGGAYDKARYLQ | 591 | Q96J66 | |
| AFLTGAMQNYARKYT | 2951 | Q6ZR08 | |
| LGAARRSQYYMKYGN | 271 | Q53F19 | |
| GYKFLYCSARAIGMA | 716 | Q14693 | |
| LYRTGKSYLMNKLAG | 46 | P32455 | |
| LYRTGKSYLMNKLAG | 46 | P32456 | |
| LYRTGKSYLMNKLAG | 46 | Q9H0R5 | |
| LYRTGKSYLMNRLAG | 61 | Q96PP9 | |
| LYRTGKSYLMNKLAG | 46 | Q96PP8 | |
| LYRTGKSYLMNKLAG | 46 | Q8N8V2 | |
| LMAYGGKLKYAIYFE | 1246 | P24043 | |
| YRANKYDGSGQIAMT | 2616 | P98164 | |
| GRYYKETSGLMLDVG | 156 | Q9H008 | |
| ILNSFYGYVMRKGAR | 811 | Q07864 | |
| MYGEYVKNFDRAVGL | 246 | Q5JSP0 | |
| EGALQMRYGDLLYKS | 296 | Q8WVZ9 | |
| ATYDGQFMKLYVNGA | 201 | Q13219 | |
| MRYVASYLLAALGGN | 1 | P05387 | |
| RQGAYFYLAGNAKSM | 541 | Q9UHB4 | |
| KYGFTLRAIRVYMGD | 976 | Q9Y2H9 | |
| YAKYFQGDLQLFSME | 336 | Q15119 | |
| MYGVNYFAIRNKKGT | 216 | P35240 | |
| MNFDFDLYIVGDGKY | 591 | Q8TCU5 | |
| LACIMGYFAGKLSYV | 81 | Q9NX40 | |
| EYNGRSGYLLKPEFM | 691 | Q01970 | |
| KFADDMYSLYGGNAV | 246 | O75787 | |
| RLYYAMKGAGTRDGT | 261 | Q5VT79 | |
| VNAMILAGKAYYDGV | 41 | Q9UHR4 | |
| LYFLMRNNFDYTGKK | 1501 | Q9BZ29 | |
| LIGVFKHGYERYNAM | 1286 | Q8TD26 | |
| SSYYKGGFEQKMSRR | 81 | Q9Y5T4 | |
| EYMAGQLAAYGYKIT | 81 | Q5VV42 | |
| YMNSSKRGAVYGFKL | 776 | Q8IVF7 | |
| LKNYMDAQYYGEIGI | 71 | P07339 | |
| LKGTVYNYRTSGMQF | 841 | P01031 | |
| AARTLGMVYIYDGKN | 276 | P06756 | |
| TKMINAGLRYGYEYL | 1281 | Q8WXX0 | |
| GKSFLLDFMLRYMYN | 106 | Q8NHH9 | |
| GKRMGFLYLTFYGHT | 166 | O75936 | |
| LSKMGYDFDYRGTVN | 1216 | O60503 | |
| GAGVMSVYLFTKRYA | 191 | P62955 | |
| KNMEVRAIFTGYYGK | 386 | P09543 | |
| YSYGLQGGMAFLDKR | 221 | Q6DD88 | |
| YMNSSKRGAVYGFKL | 831 | Q96PY5 | |
| NYMNSSKRGAAYGFR | 846 | O95466 | |
| YFSFYMGSKTLRGRN | 226 | P12314 | |
| GKYEGLTKNYMDYLS | 401 | Q9NV70 | |
| MRYYGICVKDSFLGA | 186 | Q96KS0 | |
| AENGMTFSRLLNYKY | 541 | Q8TDG4 | |
| RNYMPLAFSDKYGLG | 171 | Q9UJW0 | |
| NSVAYYGLAMDLQKF | 351 | A6NK97 | |
| YGLAMDLQKFGLSLY | 356 | A6NK97 | |
| GVMKDGVNSANRYYL | 536 | Q9Y2H2 | |
| DYYFLSIGLVMLGKF | 421 | Q9H015 | |
| LREMGKGYLALCSYN | 466 | P30260 | |
| LLGLNFYGMDYATSK | 296 | Q9BWS9 | |
| EGALQMRYGDLLYKS | 296 | Q86V97 | |
| MFGYKAKFGLYSSNL | 411 | Q6ZNG9 | |
| YFLLVLYMGQIKGAF | 11 | Q5J8X5 | |
| QYLGYRKMFLGDAVD | 416 | Q9BVL2 | |
| QLYKQASGTMVYGLF | 311 | P41218 | |
| LGLSNAKLSYYDGMI | 691 | P11717 | |
| AGFTAAYSEKGLVYM | 1536 | P11717 | |
| SGYKFGVLAKIVNYM | 71 | P29084 | |
| FGLLRGREFYMKDMY | 196 | Q7L3T8 | |
| LGAMTSLGSYNKYKY | 306 | P31641 | |
| KYMVTDGAAYIGNFD | 441 | Q8N7P1 | |
| NDVYVYGMRGRKSSG | 511 | P09917 | |
| RYLMKLEGSGSYNKG | 66 | A0A075B6I1 | |
| AKGYYVYRDMLGEKG | 71 | Q7L592 | |
| YGIGMEYDQAKALIY | 191 | Q5TEA6 | |
| KALIYYTFGSAGGNM | 201 | Q5TEA6 | |
| IKGYYRRAASNMALG | 96 | P53041 | |
| LFYRTYMLFKNASGK | 241 | Q7Z3Q1 | |
| YQVDLGDGFKAMYVN | 816 | Q96PQ0 | |
| LKEIGFINYYGMQRF | 366 | Q96PZ0 | |
| FRKKNITYYDSMGGI | 541 | Q9P0U3 | |
| KYLLAMVIAYFSRAG | 136 | P0DUX0 | |
| KYLLAMVIAYFSRAG | 136 | P0DTA3 | |
| KYLLAMVIAYFSRAG | 136 | P0DUD1 | |
| GKNIAMYRNEGFYAD | 381 | Q5T5P2 | |
| EVGNYLRMFRGSLYK | 31 | Q12824 | |
| KVYQTDGLKGFYRGM | 166 | Q96CQ1 | |
| DGLKGFYRGMSASYA | 171 | Q96CQ1 | |
| TEAFKYFLQGMGYIA | 276 | Q9ULP0 | |
| YFLQGMGYIAYLKDR | 281 | Q9ULP0 | |
| MGYIAYLKDRRLSGG | 286 | Q9ULP0 | |
| YSAARAIAGMYKQRL | 426 | Q96M27 | |
| TNSYRMGKEGNYDLK | 641 | Q9BVR0 | |
| YQKMARALRNYGRSG | 166 | Q8N5J4 | |
| SYKYKDFGQMGLRLE | 546 | Q9H930 | |
| RYFQGDLKLYSMEGV | 336 | Q15120 | |
| LGSLFSKMYVDIGYV | 226 | Q9Y6L6 | |
| LINNIKYYDGFMGQR | 1286 | Q8N122 | |
| KYYDGFMGQRVGAIS | 1291 | Q8N122 | |
| GYKAVYRLCFGLAMF | 86 | Q9NRX5 | |
| MFRSGIYQVGYDDKL | 241 | Q8IW75 | |
| LKALGYMERAAESYG | 466 | Q9Y5Q9 | |
| YLHMDGRGNYEFKQI | 636 | P28288 | |
| GYMKINTLQVFGYSL | 676 | Q9C0B6 | |
| MKGDYYRYLAEVAAG | 121 | P63104 | |
| KQGRRYLELMYAGAA | 41 | A6NFN9 | |
| IVFANSMGKGYYLKG | 186 | Q53RT3 | |
| DFLYVGVMTAQKYLG | 171 | Q70JA7 | |
| LMYGRYTQDLGAFAK | 21 | P51788 | |
| FGSKMYYFGIAALDR | 946 | A5YKK6 | |
| IAKSMAGYYQESGRA | 336 | O94762 | |
| IFAHVGQLTGMYRYK | 581 | Q6P2Q9 | |
| ALRDRYLGLQMGYKA | 601 | Q92959 | |
| RDLLGFRTSKYAMFY | 776 | P48995 | |
| DAGYRMYRKSQATGF | 281 | P48454 | |
| YMKNGQGFALVYSIT | 71 | A6NIZ1 | |
| RYYRAGLLQKYMDEG | 336 | Q4W5G0 | |
| NMGGEQVYLFDLTYK | 286 | Q8N5D0 | |
| RQSFMFYGAGYQVEK | 316 | O15393 | |
| QIGKCYYRLGMYREA | 256 | Q8TAM2 | |
| AYSGYKYVGMILSVL | 206 | O95070 | |
| DLYALAMGYSGQLKS | 1161 | Q8NI27 | |
| LQGAYFQQLYGMKKG | 2366 | Q9C0A1 | |
| MTPAQRGKGLYADYL | 136 | A6NFA1 | |
| MKFAYRFSNLLGTVY | 1 | Q15269 | |
| KYLLAMVIAYFSRAG | 136 | P0DUX1 | |
| KYLLAMVIAYFSRAG | 136 | A0A494C0Z2 | |
| KYLLAMVIAYFSRAG | 136 | P0DUD3 | |
| KYLLAMVIAYFSRAG | 136 | P0DUD4 | |
| KYLLAMVIAYFSRAG | 136 | P0DUD2 | |
| QIYYMGRFKIDLGIF | 646 | Q9NXL6 | |
| GYLGDRYNRKYLMCG | 116 | Q9H2V7 | |
| YGAKRFYDNIEDMIG | 471 | Q9NSD5 | |
| LGSLFAKMYVDIGYV | 226 | Q9NPD5 | |
| MYSAGYEKQKGRLNA | 71 | A0A075B6U4 | |
| YFSSRKRYGVAANNM | 1291 | Q92576 | |
| LYQEGCGKKMYSFLR | 201 | O95859 | |
| RKYFVDVAMGYKYGQ | 191 | Q8IWU9 | |
| FQGGGYSNKAMYIRV | 61 | Q7Z4N2 | |
| GKVFNYGGYLSVHMR | 431 | Q6ZN19 | |
| GYMGTSAFVRKIYTN | 571 | Q9HD45 | |
| LGRIGISAMYFYHKL | 1361 | Q8N9V7 | |
| YVKGIYSFGLMETNF | 181 | Q5R3I4 | |
| AYAALGTAYRMIQKY | 756 | Q96AY4 | |
| IAIDSKYSKAYGRMG | 146 | Q96EQ0 | |
| KYSKAYGRMGLALTA | 151 | Q96EQ0 | |
| KYLLAMVIAYFSRAG | 136 | A0A494C191 | |
| RASYKYKDFGQMGFR | 831 | Q13342 | |
| ARLDTYMGKVFCYLG | 486 | Q6PGP7 | |
| NQYLDKMGYGIGTRL | 41 | Q5T215 | |
| DFRFGKTYLKGMRYA | 161 | Q9NV66 | |
| KTYLKGMRYAVFGLG | 166 | Q9NV66 | |
| LAGKVQFGYVYGMSA | 166 | Q8N8F6 | |
| SRVGGIMRGEKNYYF | 36 | Q9Y4F4 | |
| IMRGEKNYYFRGAAG | 41 | Q9Y4F4 | |
| NYKRSLATYMRSLGG | 116 | Q14691 | |
| VGLLMAVFSDKGDYY | 651 | Q15849 | |
| YRSMNGKGPVYLLFS | 446 | Q9Y5A9 | |
| QYLLTGRVYDGKMYT | 101 | P35625 | |
| RSRMNAYKGLASAAY | 216 | Q9HCX4 | |
| YFRNYMSEHLLKAGA | 481 | P53350 | |
| GYFLRAKLYFSRLMG | 1456 | P35573 | |
| NGYKFLYCSARAIGM | 726 | Q92539 | |
| YARDAMAKAVYGRTF | 341 | Q8N1T3 | |
| GAGKTVSAKYAMRYF | 166 | Q9Y4I1 | |
| GAGKTVSAKYAMRYF | 166 | Q9ULV0 | |
| VSAKYAMRYFATVGG | 171 | Q9ULV0 | |
| YQSYFSRGGAKFIGM | 676 | Q5VVJ2 | |
| GEVYYKRADMAIGSL | 496 | Q14957 |